<SEC-DOCUMENT>0001213900-24-094644.txt : 20241105
<SEC-HEADER>0001213900-24-094644.hdr.sgml : 20241105
<ACCEPTANCE-DATETIME>20241105172734
ACCESSION NUMBER:		0001213900-24-094644
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20241105
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241105
DATE AS OF CHANGE:		20241105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Peraso Inc.
		CENTRAL INDEX KEY:			0000890394
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				770291941
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-32929
		FILM NUMBER:		241428625

	BUSINESS ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		408 418 7500

	MAIL ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MoSys, Inc.
		DATE OF NAME CHANGE:	20060530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MONOLITHIC SYSTEM TECHNOLOGY INC
		DATE OF NAME CHANGE:	19960613
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0220119-8k_peraso.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:PRSO="http://perasoinc.com/20241105">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_PRSO_perasoinc.com_20241105 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20241105_20241105 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000890394 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000004" name="dei:EntityCentralIndexKey">0000890394</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prso-20241105.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000890394</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-05</xbrli:startDate>
        <xbrli:endDate>2024-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20241105__20241105_zIyf8EClX873"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event Reported):
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20241105__20241105_z2otvEE7Yazc"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November 5, 2024</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20241105__20241105_zVBkLKB8YZBl"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000011" name="dei:EntityRegistrantName">PERASO INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact Name of Registrant as Specified in Charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_906_edei--EntityFileNumber_c20241105__20241105_za8kYKQLmLKd"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000012" name="dei:EntityFileNumber">000-32929</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20241105__20241105_zn6bqDcLwxvd"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center; font-size: 10pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20241105__20241105_zrXKNRudtZWb"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000014" name="dei:EntityTaxIdentificationNumber">77-0291941</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of Incorporation)</p></td>
    <td style="text-align: center; font-size: 10pt">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification Number)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20241105__20241105_zRqYbfZ1lkU3"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000015" name="dei:EntityAddressAddressLine1">2309 Bering Dr.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityAddressCityOrTown_c20241105__20241105_ztc2bNccS2v"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000016" name="dei:EntityAddressCityOrTown">San Jose</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20241105__20241105_zFKi9ZO85ofd"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20241105__20241105_zWp0mZmcXyN3"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000018" name="dei:EntityAddressPostalZipCode">95131</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices, with zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration: underline">(<span id="xdx_908_edei--CityAreaCode_c20241105__20241105_zs2K1UYYEOKi"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000019" name="dei:CityAreaCode">408</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20241105__20241105_zU4fuiUXAJW4"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000020" name="dei:LocalPhoneNumber">418-7500</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--WrittenCommunications_c20241105__20241105_zLqiEHndwR2c"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20241105__20241105_zpmuE6SLViH8"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20241105__20241105_zl8uKTmfQvMa"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20241105__20241105_zWo6ThvwYTr3"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center; font-size: 10pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center; font-size: 10pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20241105__20241105_zngYwT2PE5s9"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center; font-size: 10pt">&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20241105__20241105_zyTpKObBMRze"><ix:nonNumeric contextRef="AsOf2024-11-05" id="Fact000026" name="dei:TradingSymbol">PRSO</ix:nonNumeric></span></span></td>
    <td style="text-align: center; font-size: 10pt">&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90B_edei--SecurityExchangeName_c20241105__20241105_zXRrWp5ACWZb"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span id="xdx_904_edei--EntityEmergingGrowthCompany_c20241105__20241105_zmK7vVlVlnm7"><ix:nonNumeric contextRef="AsOf2024-11-05" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 5, 2024, Peraso Inc. (the &#8220;Company&#8221;)
entered into inducement offer letter agreements (the &#8220;Inducement Letters&#8221;) with certain holders (the &#8220;Holders&#8221;)
of existing Series B warrants of the Company to purchase up to an aggregate of 2,246,030 shares of the Company&#8217;s common stock, par
value $0.001 per share (&#8220;Common Stock&#8221;), having an original exercise price of $2.25 per share, issued to the Holders on February
8, 2024 with a current expiration date of November 8, 2024 (the &#8220;Existing Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Inducement Letters, the Holders
agreed to exercise for cash their Existing Warrants at a reduced exercise price of $1.30 per share (the &#8220;Reduced Exercised Price&#8221;)
in consideration for the Company&#8217;s agreement to issue in a private placement (i) new Series C common stock purchase warrants (the
&#8220;Series C Warrants&#8221;) to purchase an aggregate of 2,246,030 shares of Common Stock (the &#8220;Series C Warrant Shares&#8221;),
and (ii) new Series D common stock purchase warrants (the &#8220;Series D Warrants,&#8221; and collectively with the Series C Warrants,
the &#8220;New Warrants&#8221;) to purchase an aggregate of 2,246,030 shares of Common Stock (the &#8220;Series D Warrant Shares,&#8221;
and collectively with the Series C Warrants Shares, the &#8220;New Warrant Shares&#8221;), as described below (the &#8220;Offering&#8221;).
In connection with the Offering, the Company also agreed to reduce the exercise price of the Existing Warrants to purchase an aggregate
of 1,728,490 shares of Common Stock for all holders of the Existing Warrants not participating in the Offering to the Reduced Exercise
Price for the remaining term of the Existing Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The closing of the transactions contemplated pursuant
to the Inducement Letters is expected to occur on or about November 6, 2024, subject to satisfaction of customary closing conditions.
The Company expects to receive aggregate gross proceeds of approximately $2.9 million from the exercise of the Existing Warrants by the
Holders, before deducting placement agent fees and other Offering expenses payable by the Company. The Company intends to use the net
proceeds for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company engaged Ladenburg Thalmann &amp; Co.
Inc. (the &#8220;Placement Agent&#8221;) to act as its exclusive placement agent in connection with the transactions summarized above
and has agreed to pay the Placement Agent a cash fee equal to 8.0% of the gross proceeds received from the Holders&#8217; exercise of
their Existing Warrants, as well as a management fee equal to 1.0% of the total gross proceeds from the Offering, pursuant to that certain
engagement letter, by and between the Company and the Placement Agent, dated as of December 4, 2023, as amended (the &#8220;Engagement
Letter&#8221;). Pursuant to the Engagement Letter, the Company agreed to reimburse the Placement Agent for its expenses in connection
with the Offering in an amount up to $45,000. The Company also agreed to issue to the Placement Agent or its designees warrants (the &#8220;Placement
Agent Warrants&#8221;) to purchase up to 7.0% of the aggregate number of shares of Common Stock issued pursuant to the Inducement Letters
to the Holders who agreed to exercise their Existing Warrants (the &#8220;Placement Agent Warrant Shares&#8221;). The Placement Agent
Warrants will have substantially the same terms as the Series C Warrants, except that the Placement Agent Warrants will be exercisable
until the five-year anniversary of the date of issuance and will have an exercise price equal to 125% of the Reduced Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance and resale of the shares of Common
Stock underlying the Existing Warrants has been registered pursuant to an existing registration statement on Form S-1 (File No. 333-276247),
which was declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 6, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has agreed to file a registration
statement providing for the resale of the New Warrant Shares (the &#8220;Resale Registration Statement&#8221;) within 30 calendar days
of November 5, 2024, and to use commercially reasonable efforts to cause the Resale Registration Statement to be declared effective by
the SEC within 60 calendar days (or 90 calendar days if the SEC notifies the Company that it will review the registration statement) following
the filing of the initial Resale Registration Statement and to keep the Resale Registration Statement effective at all times until the
earlier of when (i) the Holders no longer own any New Warrants or New Warrant Shares or (ii) the Delegend Date (as defined in the Inducement
Letters).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Inducement Letters, the Company
agreed not to issue any shares of Common Stock or Common Stock equivalents or to file any other registration statement with the SEC (in
each case, subject to certain exceptions) until thirty (30) days after November 5, 2024. The Company has also agreed not to effect or
agree to effect any Variable Rate Transaction (as defined in the Inducement Letters) until one hundred twenty (120) calendar days after
November 5, 2024 (subject to certain exceptions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terms of the New Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Duration and Exercise Price</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each New Warrant will have an exercise price equal
to $1.61 per share. The Series C Warrants will be exercisable upon issuance until the six-month anniversary of the date of issuance. The
Series D Warrants will be exercisable upon issuance until the five-year anniversary of the date of issuance. The exercise price and number
of New Warrant Shares issuable upon exercise of the New Warrants is subject to appropriate adjustment in the event of stock dividends,
stock splits, subsequent rights offerings, pro rata distributions, reorganizations, or similar events affecting the Common Stock and the
exercise price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercisability</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The New Warrants will be exercisable, at the option
of each holder, in whole or in part, by delivering a duly executed notice of exercise accompanied by payment in full for the number of
shares of Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together
with its affiliates) may not exercise any portion of such holder&#8217;s New Warrants to the extent that the holder would own more than
4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock immediately after exercise, except that upon prior notice
from the holder to the Company, the holder may increase or decrease the amount of ownership of outstanding stock after exercising the
holder&#8217;s New Warrants up to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise,
as such percentage ownership is determined in accordance with the terms of the New Warrants, provided that any increase will not be effective
until 61 days following notice to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cashless Exercise</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, at the time a holder exercises its New Warrants,
a registration statement registering the resale of the New Warrant Shares by the holder under the Securities Act of 1933, as amended (the
&#8220;Securities Act&#8221;) is not then effective or available, then in lieu of making the cash payment otherwise contemplated to be
made upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either
in whole or in part), the net number of shares of Common Stock determined according to a formula set forth in the New Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Rights as a Stockholder</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the New Warrants
or by virtue of the holder&#8217;s ownership of shares of Common Stock, such holder of New Warrants does not have the rights or privileges
of a holder of Common Stock, including any voting rights, until such holder exercises such holder&#8217;s New Warrants. The New Warrants
provide that the holders of the New Warrants have the right to participate in distributions or dividends paid on shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fundamental Transactions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If at any time the New Warrants are outstanding,
the Company, either directly or indirectly, in one or more related transactions effects a Fundamental Transaction (as defined in the New
Warrants), a holder of New Warrants will be entitled to receive, the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if the Company is the surviving corporation, and any additional consideration receivable as a result of the Fundamental
Transaction by a holder of the number of shares of Common Stock for which the New Warrants are exercisable immediately prior to the Fundamental
Transaction. As an alternative, and at the holder&#8217;s option in the event of a Fundamental Transaction (other than a merger or consolidation
of the Company with any Subsidiary or Affiliate whereby the stockholders of the Company do not own at least (x) 50.1% of the outstanding
shares of Common Stock and (y) 50.1% of the voting power of the surviving entity immediately after such merger or consolidation), exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), the Company shall purchase the unexercised portion of the New Warrants
from the holder by paying to the holder an amount of cash equal to the Black Scholes Value (as defined in the New Warrants) of the remaining
unexercised portion of the New Warrants on the date of the consummation of such Fundamental Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Waivers and Amendments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The New Warrants may be modified or amended, or
the provisions of the New Warrants waived with the Company&#8217;s and the holders&#8217; written consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Call Provision (Series D Warrants)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series D Warrants are callable by the Company
as follows: Subject to certain exceptions, if, after the initial exercise date of the Series D Warrants, (i) the closing price for any
20 of 30 consecutive trading days (the &#8220;Measurement Period,&#8221; which 20 of 30 consecutive trading day period shall not have
commenced until after such initial exercise date) exceeds $4.83 (subject to adjustment for forward and reverse stock splits, recapitalizations,
stock dividends and the like after such initial exercise date), (ii) the average daily dollar volume for such Measurement Period exceeds
$500,000 per trading day and (iii) the holder of the Series D Warrant is not in possession of any information that constitutes, or might
constitute, material non-public information which was provided by the Company, any of its subsidiaries, or any of their officers, directors,
employees, agents or affiliates, then the Company may, within 1 trading day of the end of such Measurement Period, upon notice to the
Series D Warrant holder (a &#8220;Call Notice&#8221;), call for cancellation of all or any portion of the Series D Warrants for which
a notice of exercise has not yet been delivered for consideration equal to $0.001 per Series D Warrant Share. If the conditions set forth
in the Series D Warrant for such call are satisfied from the period from the date of the Call Notice through and including the Call Date
(as defined below), then any portion of the Series D Warrant subject to such Call Notice for which a notice of exercise shall not have
been received by the Call Date will be cancelled at 6:30 p.m. (New York City time) on the tenth trading day after the date the Call Notice
is received by the Holder (such date and time, the &#8220;Call Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The forms of Inducement Letter, Series C Warrant,
Series D Warrant and Placement Agent Warrant are attached as Exhibits 10.1, 4.1, 4.2 and 4.3, respectively. The descriptions of the terms
of the Inducement Letters, the Series C Warrants, the Series D Warrants and the Placement Agent Warrants are not intended to be complete
and are qualified in their entirety by reference to such exhibits. The Inducement Letters contain customary representations, warranties
and covenants by the Company which were made only for the purposes of such agreements and as of specific dates, were solely for the benefit
of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The New Warrants, Placement Agent Warrants, New
Warrant Shares and Placement Agent Warrant Shares have not been registered under the Securities Act and were offered pursuant to the exemption
from registration provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The description of the New Warrants and the Placement
Agent Warrants under Item 1.01 of this Form 8-K is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55pt"><b>Item 3.03 Material Modifications to Rights
of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The disclosure set forth under Item 1.01 of this
Current Report on Form 8-K is incorporated herein by reference into this Item 3.03 in its entirety.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 5, 2024, the Company issued a press
release announcing the transactions described in Item 1.01 above. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit No.</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea022011901ex4-1_peraso.htm">Form of Series C Warrant.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea022011901ex4-2_peraso.htm">Form of Series D Warrant.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea022011901ex4-3_peraso.htm">Form of Placement Agent Warrant.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea022011901ex10-1_peraso.htm">Form of Inducement Letter.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea022011901ex99-1_peraso.htm">Press Release dated November 5, 2024.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PERASO INC.</b></span></td></tr>
  <tr>
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 4%; text-align: justify">&#160;</td>
    <td style="width: 36%; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 5, 2024</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ James Sullivan</i></span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Sullivan</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">4</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZF+3vpktLLWIVKSJuR5vKYDspmfHvSN7SsUUMgRDe+94TwhclLVWHDMdFXcEe+6GTFqHGFhn1GZ0jX60zcLfGizKWpbbj+wNzcgw6Jp1FyckJo/WuDDYZhOE8SOdRAkGcpTHsNsL76jnpVjWorZIdSN3AjmlghVbya0rYyydp6l9j1QHZKNIubhZM8huiIIxgS3f5IL4aqKpceP44niiZboNzFU+L+ktC0WHv6sxE/9f7AAcDSo0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea022011901ex4-1_peraso.htm
<DESCRIPTION>FORM OF SERIES C WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES C COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: [_____]</TD>
  <TD STYLE="text-align: right; width: 50%">Initial Exercise Date: [_______], 2024</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SERIES C COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [__________] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [_____], 2025<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>
the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to [_____] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Insert the date that is the 6 month anniversary of the Initial
Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Inducement
Agreements</U>&rdquo; means that certain inducement letter, dated as of November [____], 2024, between the Company and the Holder and
substantially similar letters entered into with other holders of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series C Common Stock purchase warrants issued by the Company pursuant to the Inducement Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.61, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 95.25pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(A)</TD>
    <TD STYLE="text-align: center; width: 0.25in">=</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, or the
Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
on a Trading Day) pursuant to Section 2(a) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD>
    <TD STYLE="text-align: center; width: 0.25in">=</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD>
    <TD STYLE="text-align: center; width: 0.25in">=</TD><TD STYLE="text-align: justify"> the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to
take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company
shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such
failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, other than in clause (i) above in connection with a merger or consolidation of the Company
with any Subsidiary or Affiliate whereby the stockholders of the Company do not own at least (x) 50.1% of the outstanding shares of Common
Stock and (y) 50.1% of the voting power of the surviving entity immediately after such merger or consolidation, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in
the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock
or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not
offered or paid any consideration in such Fundamental Transaction <FONT STYLE="background-color: white">and the Company remains the Successor
Entity following such Fundamental Transaction</FONT>, such holders of Common Stock will be deemed to have received common stock of the
Successor Entity in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the
Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (i) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of such date of request, (ii)
an expected volatility equal to the remaining term of this Warrant obtained from the HVT function on Bloomberg as of the Trading Day
immediately prior to the public announcement of the applicable Fundamental Transaction or, if the Fundamental Transaction is not publicly
announced, the date the Fundamental Transaction is consummated, (iii) the underlying price per share used in such calculation shall be
the greater of (A) the sum of the price per share being offered in cash, if any, plus the per share value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (B) the greater of (x) the last weighted average price of the Common Stock
immediately prior to the public announcement of such Fundamental Transaction and (y) the last weighted average price of the Common Stock
immediately prior to the consummation of such Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
the Inducement Agreements, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of the Inducement Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com, or such
other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of
the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to
5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)<BR STYLE="clear: both"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&nbsp;<B>PERASO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&nbsp;Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; in
lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; if
permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT> ________________________</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT> _________________________</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea022011901ex4-2_peraso.htm
<DESCRIPTION>FORM OF SERIES D WARRANT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. <B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES D COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">Warrant Shares: [_____]</TD><TD STYLE="text-align: right; width: 50%"> Initial Exercise Date: [_______], 2024</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SERIES D COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [__________] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [_____], 2029<FONT STYLE="font-size: 10pt"><SUP>1
</SUP></FONT>the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to [_____] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a
Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as
applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the
most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">Insert the date that is the 5 year anniversary of the Initial
Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Inducement
Agreements</U>&rdquo; means that certain inducement letter, dated as of November [____], 2024, between the Company and the Holder and
substantially similar letters entered into with other holders of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series D Common Stock purchase warrants issued by the Company pursuant to the Inducement Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy
submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check
drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of
guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)
Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.61, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in">(A) =</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, or the
Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
on a Trading Day) pursuant to Section 2(a) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(B) =</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to
take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of
Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is
solely due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the
number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In
with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The
Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon
request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp;
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company
each time it delivers a Notice of Exercise that such Notice of Exercise has not violated the restrictions set forth in this
paragraph, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a
determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the
Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of
shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon
notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that
the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the
61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and
implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Call
Provision</U>. Subject to the provisions of Section 2(e) and this Section 2(f), if, after the Initial Exercise Date, (i) the closing
price for any 20 of 30 consecutive Trading Days (the &ldquo;<U>Measurement Period</U>,&rdquo; which 20 of 30 consecutive Trading Day
period shall not have commenced until after the Initial Exercise Date) exceeds $4.83 (subject to adjustment for forward and reverse
stock splits, recapitalizations, stock dividends and the like after the Initial Exercise Date), (ii) the average daily dollar volume
for such Measurement Period exceeds $500,000 per Trading Day and (iii) the Holder is not in possession of any information that
constitutes, or might constitute, material non-public information which was provided by the Company, any of its Subsidiaries, or any
of their officers, directors, employees, agents or Affiliates, then the Company may, within 1 Trading Day of the end of such
Measurement Period, call for cancellation of all or any portion of this Warrant for which a Notice of Exercise has not yet been
delivered (such right, a &ldquo;<U>Call</U>&rdquo;) for consideration equal to $0.001 per Warrant Share. To exercise this right, the
Company must deliver to the Holder an irrevocable written notice (a &ldquo;<U>Call Notice</U>&rdquo;), indicating therein the
portion of unexercised portion of this Warrant to which such notice applies. If the conditions set forth below for such Call are
satisfied from the period from the date of the Call Notice through and including the Call Date (as defined below), then any portion
of this Warrant subject to such Call Notice for which a Notice of Exercise shall not have been received by the Call Date will be
cancelled at 6:30 p.m. (New York City time) on the tenth Trading Day after the date the Call Notice is received by the Holder (such
date and time, the &ldquo;<U>Call Date</U>&rdquo;). Any unexercised portion of this Warrant to which the Call Notice does not
pertain will be unaffected by such Call Notice. In furtherance thereof, the Company covenants and agrees that it will honor all
Notices of Exercise with respect to Warrant Shares subject to a Call Notice that are tendered through 6:30 p.m. (New York City time)
on the Call Date. The parties agree that any Notice of Exercise delivered following a Call Notice which calls less than all of the
Warrants shall first reduce to zero the number of Warrant Shares subject to such Call Notice prior to reducing the remaining Warrant
Shares available for purchase under this Warrant. For example, if (A) this Warrant then permits the Holder to acquire 100 Warrant
Shares, (B) a Call Notice pertains to 75 Warrant Shares, and (C) prior to 6:30 p.m. (New York City time) on the Call Date the Holder
tenders a Notice of Exercise in respect of 50 Warrant Shares, then (x) on the Call Date the right under this Warrant to acquire 25
Warrant Shares will be automatically cancelled, (y) the Company, in the time and manner required under this Warrant, will have
issued and delivered to the Holder 50 Warrant Shares in respect of the exercises following receipt of the Call Notice, and (z) the
Holder may, until the Termination Date, exercise this Warrant for 25 Warrant Shares (subject to adjustment as herein provided and
subject to subsequent Call Notices). Subject again to the provisions of this Section 2(f), the Company may deliver subsequent Call
Notices for any portion of this Warrant for which the Holder shall not have delivered a Notice of Exercise. Notwithstanding anything
to the contrary set forth in this Warrant, the Company may not deliver a Call Notice or require the cancellation of this Warrant
(and any such Call Notice shall be void), unless, from the beginning of the Measurement Period through the Call Date, (1) the
Company shall have honored in accordance with the terms of this Warrant all Notices of Exercise delivered by 6:30 p.m. (New York
City time) on the Call Date, and (2) a registration statement shall be effective as to all Warrant Shares and the prospectus
thereunder available for use by the Holder for the resale of all such Warrant Shares, and (3) the Common Stock shall be listed or
quoted for trading on the Trading Market, and (4) there is a sufficient number of authorized shares of Common Stock for issuance of
all Warrant Shares under the Warrants, and (5) the issuance of all Warrant Shares subject to a Call Notice shall not cause a breach
of any provision of Section 2(e) herein. The Company&rsquo;s right to call the Warrants under this Section 2(f) shall be exercised
ratably among the Holders based on each Holder&rsquo;s initial purchase of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re&#45;classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if
the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on
which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of
which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the
Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to
such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such
Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company<FONT STYLE="font-family: Times New Roman, Times, Serif">, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, other than in clause (i) above in connection with a merger or consolidation of the Company with any Subsidiary or Affiliate whereby the stockholders of the Company do not own at least (x) 50.1% of the outstanding shares of Common Stock and (y) 50.1% of the voting power of the surviving entity immediately after such merger or consolidation, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the </FONT>same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">and the Company remains the Successor Entity following such Fundamental Transaction</FONT>, such holders of Common Stock will be deemed to have received common stock of the Successor Entity in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of such date of request, (ii) an expected volatility equal to the remaining term of this Warrant obtained from the HVT function on Bloomberg as of the Trading Day immediately prior to the public announcement of the applicable Fundamental Transaction or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is consummated, (iii) the underlying price per share used in such calculation shall be the greater of (A) the sum of the price per share being offered in cash, if any, plus the per share value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (B) the greater of (x) the last weighted average price of the Common Stock immediately prior to the public announcement of such Fundamental Transaction and (y) the last weighted average price of the Common Stock immediately prior to the consummation of such Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. <FONT STYLE="font-family: Times New Roman, Times, Serif">For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company
shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a
party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the
applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in which
case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date
on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the
Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to
exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such
notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions
of the Inducement Agreements, this Warrant and all rights hereunder (including, without limitation, any registration rights) are
transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and,
if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor
a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the
Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)
Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant,
if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a
new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-underline-style: double">d) </FONT><U>Transfer
Restrictions</U>. <FONT STYLE="text-underline-style: double">If</FONT>, at the <FONT STYLE="text-underline-style: double">time of the
surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered
pursuant to an effective </FONT>registration <FONT STYLE="text-underline-style: double">statement under the Securities Act</FONT> and
<FONT STYLE="text-underline-style: double">under applicable state securities or blue sky laws or (ii) eligible for resale without volume
or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition
of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of the Inducement
Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to
the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be
necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the
generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor
upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in
order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com, or such
other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of
the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to
5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-transform: uppercase">PERASO INC.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: &nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>PERASO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: normal 10pt Times New Roman, Times, Serif"><TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ________________________</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT>  _________________________</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea022011901ex4-3_peraso.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">Warrant Shares: [_____]</TD><TD STYLE="text-align: right; width: 50%">Initial Exercise Date: [_______], 2024</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [__________] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [_____], 2029<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>
the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to [_____] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b). This Warrant is being issued pursuant to that certain Investment Banking Agreement, dated as of December 4, 2023, as amended,
(the &ldquo;<U>Investment Banking Agreement</U>&rdquo;), by and between the Company and Ladenburg Thalmann &amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">Insert the date that is the 5 year anniversary of the Initial
Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Placement Agent Common Stock purchase warrants issued by the Company pursuant to the Investment Banking Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.625, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 95.25pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD>
    <TD STYLE="text-align: center; width: 0.2in">=</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal
securities laws) on such Trading Day, or the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as
of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD><TD STYLE="text-align: center; width: 0.2in">=</TD>
                                                                                <TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD><TD STYLE="text-align: center; width: 0.2in">=</TD>
                                                                                <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to
take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 1.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder
and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective
until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of
the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, other
than in clause (i) above in connection with a merger or consolidation of the Company with any Subsidiary or Affiliate whereby the
stockholders of the Company do not own at least (x) 50.1% of the outstanding shares of Common Stock and (y) 50.1% of the voting
power of the surviving entity immediately after such merger or consolidation, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this
Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the
remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of
consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being
offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice
to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction <FONT STYLE="background-color: white">and
the Company remains the Successor Entity following such Fundamental Transaction</FONT>, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on
Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the
remaining term of this Warrant as of such date of request, (ii) an expected volatility equal to the remaining term of this Warrant
obtained from the HVT function on Bloomberg as of the Trading Day immediately prior to the public announcement of the applicable
Fundamental Transaction or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is
consummated, (iii) the underlying price per share used in such calculation shall be the greater of (A) the sum of the price per
share being offered in cash, if any, plus the per share value of any non-cash consideration, if any, being offered in such
Fundamental Transaction and (B) the greater of (x) the last weighted average price of the Common Stock immediately prior to the
public announcement of such Fundamental Transaction and (y) the last weighted average price of the Common Stock immediately prior to
the consummation of such Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor. The payment of
the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later
of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term
&ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer
instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or
Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the
other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and
severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com, or such
other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of
the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to
5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-transform: uppercase">PERASO INC.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Title:</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>PERASO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if
permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Holder&rsquo;s Signature: ________________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Holder&rsquo;s Address: _________________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea022011901ex10-1_peraso.htm
<DESCRIPTION>FORM OF INDUCEMENT LETTER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: right; text-indent: 0.5in">November 5, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder of Series B Warrants issued on February
8, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Inducement Offer
                                            to Exercise Series B Warrants</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Peraso Inc. (the &ldquo;<U>Company</U>&rdquo;)
is pleased to offer to you the opportunity to exercise all of the Series B warrants (CUSIP 71360T 135) to purchase an aggregate of [___]
shares of Common Stock, issued on February 8, 2024 (the &ldquo;<U>Existing Warrant(s)</U>&rdquo;) set forth on the signature page hereto
currently held by you (the &ldquo;<U>Holder</U>&rdquo;). The shares underlying the Existing Warrants (the &ldquo;<U>Warrant Shares</U>&rdquo;)
have been registered pursuant to the registration statement on Form S-1 (File No. 333-276247) (the &ldquo;<U>Registration Statement</U>&rdquo;).
The Registration Statement is currently effective, and, upon exercise of the Existing Warrants pursuant to this letter agreement (this
&ldquo;<U>Agreement</U>&rdquo;), will be effective for the issuance or sale, as the case may be, of the Warrant Shares. Capitalized terms
not otherwise defined herein shall have the meanings set forth in the applicable Existing Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration for exercising
in full, all of the Existing Warrants held by you and set forth on the signature page hereto (the &ldquo;<U>Warrant Exercise</U>&rdquo;)
at a reduced exercise price of $1.30 per share (the &ldquo;<U>Reduced Exercise Price</U>&rdquo;), the Company hereby offers to issue
you or your designee, (i) a new Series C Common Stock Purchase Warrant (the &ldquo;<U>Series C Warrant</U>&rdquo;) and (ii) a new Series
D Common Stock Purchase Warrant (the &ldquo;<U>Series D Warrant</U>&rdquo;, collectively with the Series C Warrant, the &ldquo;<U>New
Warrants</U>&rdquo;) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (&ldquo;<U>Securities Act</U>&rdquo;), each
to purchase up to such number of shares of Common Stock (&ldquo;<U>New Warrant Shares</U>&rdquo;) equal to 100% of the number of Warrant
Shares issued pursuant to the Warrant Exercise of the Existing Warrants hereunder, which New Warrants shall be substantially in the form
of <U>Annex B</U> and <U>Annex C</U> attached hereto. The Series C Warrant will be exercisable immediately upon issuance, will have a
term of exercise of six (6) months, and have an exercise price per share equal to $1.61, subject to adjustment as provided in the Series
C Warrants. The Series D Warrant will be exercisable immediately upon issuance, will have a term of exercise of five (5) years, and have
an exercise price per share equal to $1.61, subject to adjustment as provided in the Series D Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The original warrant certificates
for the New Warrants will be delivered within two (2) Business Days following payment of the Warrant Exercise Price in connection with
the Warrant Exercise pursuant to this Agreement. Notwithstanding anything herein to the contrary, in the event the Warrant Exercise would
otherwise cause the Holder to exceed the beneficial ownership limitations (&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;) set
forth in Section 2(e) of each of the Existing Warrants, the Company shall only issue such number of Warrant Shares to the Holder that
would not cause the Holder to exceed the maximum number of Warrant Shares permitted thereunder with the balance to be held in abeyance
until notice from the Holder that the balance (or portion thereof) may be issued in compliance with such limitations, which abeyance
shall be evidenced through the Existing Warrants which shall be deemed prepaid thereafter, and exercised pursuant to a Notice of Exercise
in the applicable Existing Warrant (provided no additional exercise price shall be payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Expressly subject to the
paragraph immediately following this paragraph below, the Holder may accept this offer by signing this letter below, with such acceptance
constituting the Holder&rsquo;s notice and authorization to consummate the Warrant Exercise in the amount and for the aggregate exercise
price set forth on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise Price</U>&rdquo;) on or before 9:00 a.m.
Eastern Time on November 5, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Company
agrees to the representations, warranties and covenants set forth on <U>Annex A</U> attached hereto. The Holder represents and warrants
that it is an &ldquo;accredited investor,&rdquo; as defined in Rule 501 of the Securities Act, and agrees that the New Warrants will
contain restrictive legends when issued, and neither the New Warrants nor the shares of Common Stock issuable upon exercise of the New
Warrants will be registered under the Securities Act upon issuance. The Holder also acknowledges and agrees that as a part of this transaction,
the Company shall reduce the exercise price of the Existing Warrants for all holders of the Existing Warrants not participating in this
transaction to the Reduced Exercise Price for the remaining term of the Existing Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Holder understands that the New Warrants and the shares of Common Stock underlying the New Warrants are not, and may never be, registered
under the Securities Act, or the securities laws of any state and, accordingly, each certificate, if any, representing such securities
shall bear a legend substantially similar to the following:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certificates or book-entry
statements evidencing shares of Common Stock underlying the New Warrants shall not contain any legend (including the legend set forth
above) (i) while a registration statement covering the resale of such Common Stock is effective under the Securities Act, (ii) following
any sale of such Common Stock pursuant to Rule 144 under the Securities Act, (iii) if such Common Stock is eligible for sale under Rule
144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such
Common Stock and without volume or manner-of-sale restrictions, (iv)&nbsp;if such Common Stock may be sold under Rule 144 and the Company
is then in compliance with the current public information required under Rule 144 as to such Common Stock, or (v) if such legend is not
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) and the earliest of clauses (i) through (v), the &ldquo;<U>Delegend
Date</U>&rdquo;)). Upon receipt of a representation letter or other documentation from the Holder that the Company may reasonably request,
the Company shall cause its counsel to issue a legal opinion to the transfer agent promptly after the Delegend Date if required by the
Company and/or the transfer agent to effect the removal of the legend hereunder, which opinion shall be in form and substance reasonably
acceptable to the Holder. If such Common Stock may be sold under Rule 144 without the requirement for the Company to be in compliance
with the current public information required under Rule 144 or if such legend is not otherwise required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Common
Stock shall be issued free of all legends. The Company agrees that following the Delegend Date or at such time as such legend is no longer
required, it will, no later than one (1) Trading Day following the delivery by the Holder to the Company and/or the transfer agent of
the representation letter and other documentation referenced above and a certificate representing, or book-entry statement evidencing,
the Common Stock underlying the New Warrants issued with a restrictive legend and a representation letter from the Holder that the Company
may reasonably request (such Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to the Holder
a certificate representing, or book-entry statement evidencing, such shares that is free from all restrictive and other legends or, at
the request of the Holder shall credit the account of the Holder&rsquo;s prime broker with the Depository Trust Company System as directed
by the Holder. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the Holder&rsquo;s
other available remedies, the Company shall pay to a Holder, in cash, (i) as partial liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares (based on the VWAP of the Common Stock on the date such Warrant Shares are submitted to the Transfer Agent)
delivered for removal of the restrictive legend, $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such
damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate or book-entry statement is delivered
without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to the Holder by the Legend Removal
Date a certificate representing, or book-entry statement evidencing, the Warrant Shares so delivered to the Company by the Holder that
is free from all restrictive and other legends and (b) if after the Legend Removal Date the Holder purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock
that the Holder anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of the Holder&rsquo;s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;) over the product
of (A) such number of Warrant Shares that the Company was required to deliver to the Holder by the Legend Removal Date multiplied by
(B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by
the Holder to the Company of the applicable Warrant Shares (as the case may be) and ending on the date of such delivery and payment under
this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this offer is accepted
and the transaction documents are executed on or before 9:00 a.m. ET on November 5, 2024, then on or before 9:30 a.m. ET on the date
hereof, the Company shall issue a press release or file a Current Report on Form 8-K disclosing all material terms of the transactions
contemplated hereunder. From and after the issuance of such press release or the filing of such Current Report on Form 8-K, the Company
represents to you that it shall have publicly disclosed all material, non-public information delivered to you by the Company, or any
of their respective officers, directors, employees or agents in connection with the transactions contemplated hereunder. In addition,
effective upon the issuance of such press release or the filing of such Current Report on Form 8-K, the Company acknowledges and agrees
that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its
subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and you and your Affiliates
on the other hand, shall terminate. The Company represents, warrants and covenants that, upon acceptance of this offer and entering into
this Agreement, the shares underlying the Existing Warrants shall be issued free of any legends or restrictions on resale by Holder and
all of the Warrant Shares shall be delivered electronically through the Depository Trust Company (or &ldquo;delivery versus payment&rdquo;
if coordinated through Ladenburg Thalmann &amp; Co. Inc.) within one (1) Business Day following the date hereof (or, with respect to
Warrant Shares that would otherwise be in excess of the Beneficial Ownership Limitation, within one (1) Business Day of the date the
Company is notified by Holder that its ownership is less than the applicable Beneficial Ownership Limitation), provided the payment of
the Warrant Exercise Price is received by the Company prior to issuing such Warrant Shares. The terms of the Existing Warrants, including
but not limited to the obligations to deliver the Warrant Shares, shall otherwise remain in effect as if the acceptance of this offer
were a formal Notice of Exercise (including but not limited to any liquidated damages and compensation in the event of late delivery
of the Warrant Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company agrees that within
thirty (30) calendar days of the date of this Agreement, the Company shall file a registration statement on Form S-3 (or other appropriate
form if the Company is not then eligible to register securities on Form S-3) (the &ldquo;<U>Resale Registration Statement</U>&rdquo;)
providing for the resale by the Holders of the New Warrant Shares issued and issuable upon exercise of the New Warrants. The Company
shall use commercially reasonable efforts to cause such registration to become effective within sixty (60) calendar days (or ninety (90)
calendar days if the Commission notifies the Company that it will &ldquo;review&rdquo; the registration statement) following the initial
filing of such registration statement and to keep such registration statement effective at all times until the earlier of (i) the time
that no Holder owns any New Warrants or New Warrant Shares issuable upon exercise thereof or (ii) the Delegend Date. The Holder agrees
to furnish to the Company a completed&nbsp;questionnaire&nbsp;in the form attached as&nbsp;<U>Annex D</U>&nbsp;hereto within seven (7)
calendar days following the date hereof (a &ldquo;<U>Selling Stockholder&nbsp;Questionnaire</U>&rdquo;). The Holder further agrees that
it shall not be entitled to be named as a selling stockholder in the Resale Registration Statement or use the prospectus contained in
such registration statement for offers and resales of New Warrant Shares at any time, unless Holder has returned to the Company a completed
and signed Selling Stockholder&nbsp;Questionnaire&nbsp;in the time frame described in the previous sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that the obligations of the Holders under this Agreement are several and not joint with the obligations of any other Holder
or any other holders of warrants to purchase Common Stock of the Company (each, an &ldquo;<U>Other Holder</U>&rdquo;) under any other
agreement related to the exercise of such common stock purchase warrants (&ldquo;<U>Other Warrant Exercise Agreement</U>&rdquo;), and
the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other Warrant
Exercise Agreement. Nothing contained in this Agreement, and no action taken by the Holders pursuant hereto, shall be deemed to constitute
the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Holder and the Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Agreement and the Company acknowledges that the Holder and the Other Holders are not acting in concert or as a group
with respect to such obligations or the transactions contemplated by this Agreement or any Other Warrant Exercise Agreement. The Company
and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated hereby with
the advice of its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights, including,
without limitation, the rights arising out of this Agreement, and it shall not be necessary for any Other Holder to be joined as an additional
party in any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby represents
and warrants as of the date hereof and covenants and agrees from and after the date hereof until thirty (30) calendar days after the
date hereof, that none of the terms offered to any Other Holder with respect to any Other Warrant Exercise Agreement (or any amendment,
modification or waiver thereof) relating to any of the Existing Warrants, is or will be more favorable to such Other Holder than those
of the Holder and this Agreement, unless such terms are concurrently offered to the Holder. If, and whenever on or after the date hereof
until thirty (30) calendar days after the date hereof, the Company enters into an Other Warrant Exercise Agreement relating to the Existing
Warrants, then (i) the Company shall provide notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms
and conditions of this Agreement shall be, without any further action by the Holder or the Company, automatically amended and modified
in an economically and legally equivalent manner such that the Holder shall receive the benefit of the more favorable terms and/or conditions
(as the case may be) set forth in such Other Warrant Exercise Agreement (including the issuance of additional Warrant Shares), provided
that upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended or modified term
or condition, in which event the term or condition contained in this Agreement shall apply to the Holder as it was in effect immediately
prior to such amendment or modification as if such amendment or modification never occurred with respect to the Holder. The provisions
of this paragraph shall apply similarly and equally to each Other Warrant Exercise Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each party hereto shall pay
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this letter agreement. The Company shall pay all transfer
agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No provision of this Agreement
may be waived, modified, supplemented or amended except in a written instrument signed, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, or, in the case of a modification, supplement, or amendment, by each of the
parties hereto. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall be governed
by the laws of the State of New York without regard to the principles of conflicts of law thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">***************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To accept this offer, Holder
must counter execute this letter agreement and return the fully executed letter agreement to the Company at [***], on or before 9:00
a.m. (New York City time) on November 5, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please do not hesitate to
call me if you have any questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Sincerely yours,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">PERASO INC.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Holder: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Holder</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total Warrant Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aggregate Exercise Price: _____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Series C Warrants: (100% of total Existing Warrants
being exercised): ___________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Series C Warrants Beneficial Ownership Blocker:
<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> 4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
</FONT>9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Series D Warrants: (100% of total Existing Warrants
being exercised): ___________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Series D Warrants Beneficial Ownership Blocker:
<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> 4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
</FONT>9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DTC Instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Representations, Warranties
and Covenants of the Company</U>. The Company hereby makes the following representations and warranties to the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Registration
Statement</U>. The Warrant Shares are registered for issuance on the Registration Statement and the Company knows of no reason why such
Registration Statement shall not remain effective for the foreseeable future. The Company shall use commercially reasonable efforts to
keep the Registration Statement effective and available for use by the Holder until all Warrant Shares underlying the Existing Warrants
are sold by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement by
the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, its board of directors or its stockholders in connection
therewith. This Agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>No Conflicts</U>.
The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated
hereby do not and will not: (i) conflict with or violate any provision of the Company&rsquo;s certificate of incorporation, as amended,
bylaws, or other organizational or charter documents; or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the creation of any &nbsp;liens, claims, security interests, other encumbrances
or defects upon any of the properties or assets of the Company in connection with, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any material agreement, credit facility, debt or other
material instrument (evidencing Company debt or otherwise) or other material understanding to which such Company is a party or by which
any property or asset of the Company is bound or affected; or (iii) conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including
federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected, except, in
the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a material adverse effect upon
the business, prospects, properties, operations, condition (financial or otherwise) or results of operations of the Company, taken as
a whole, or in its ability to perform its obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Nasdaq Corporate
Governance</U>. The transactions contemplated under this Agreement, comply with all rules of the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Issuance
of the New Warrant</U>. The issuance of the New Warrants is duly authorized and, and when executed and delivered by the Company, shall
constitute a valid, legal and binding obligation of the Company, enforceable in accordance with their terms, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general
principles of equity, and the New Warrant Shares, when issued in accordance with the terms of the New Warrants, will be validly issued,
fully paid and nonassessable, free and clear of all liens imposed by the Company. The Company has reserved from its duly authorized capital
stock a number of shares of Common Stock for issuance of the New Warrant Shares in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Listing
of Common Stock.</U> The Company shall apply to list or quote all of the New Warrant Shares on the Nasdaq Capital Market and promptly
secure the listing of all of the New Warrant Shares on the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Subsequent
Equity Sales.</U> From the date hereof until thirty (30) days after the date hereof, neither the Company nor any subsidiary shall (i)
issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock
Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Resale Registration
Statement registering the New Warrant Shares. Notwithstanding the foregoing, this Section (g) shall not apply in respect of an Exempt
Issuance, except that no Variable Rate Transaction (defined below) shall be an Exempt Issuance. &ldquo;Exempt Issuance&rdquo; means the
issuance of (a) shares of Common Stock, options, restricted stock units or other equity awards to employees, officers, directors or consultants
of the Company pursuant to any stock or option plan or arrangement duly adopted for such purpose by a majority of the non-employee members
of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services
rendered to the Company, (b) shares of Common Stock upon the exercise or exchange of or conversion of any Existing Warrants and/or New
Warrants issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and
outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in
connection with stock splits or combinations) or to extend the term of such securities, (c) securities issued pursuant to acquisitions
or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued
as &ldquo;restricted securities&rdquo; (as defined in Rule 144) if issued during the prohibition period in this Section (g) and carry
no registration rights that require or permit the filing of any registration statement in connection therewith within thirty (30) days
after the date hereof, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is,
itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities, and (d) the filing of any registration statement on Form S-8 with respect to the registration of securities to be issued
pursuant to any stock or option plan described in clause (a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>Variable
Rate Transactions.</U> From the date hereof until one hundred twenty (120) calendar days following the date hereof, the Company shall
be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of common
stock or common stock equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;Variable Rate Transaction&rdquo;
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive, additional shares of common stock either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of common
stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that
is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified
or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters
into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market
offering&rdquo;, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such
agreement have actually been issued and regardless of whether such agreement is subsequently canceled; provided, however, that, after
thirty (30) calendar days following the date hereof, the entry into and/or issuance of shares of common stock in an &ldquo;at the market&rdquo;
offering with Ladenburg Thalmann &amp; Co. Inc. as sales agent shall not be deemed a Variable Rate Transaction. Any Holder shall be entitled
to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex B &ndash; Form of Series C Warrant</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex C &ndash; Form of Series D Warrant</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex D &ndash; Form of Selling Stockholder
Questionnaire</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Selling Stockholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of securities of Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), understands that the Company intends to
file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration
Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), of the shares of the Company&rsquo;s common stock, par value $0.001 per share, issuable upon exercise of certain warrants
issued on November 6, 2024 (the &ldquo;<U>Registrable Securities</U>&rdquo;) issued pursuant to the Inducement Offer Letter, dated November
5, 2024, between the Company and the undersigned (the &ldquo;<U>Inducement Offer Letter</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned beneficial owner (the &ldquo;<U>Selling
Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>QUESTIONNAIRE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Name.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Full Legal Name of Selling Stockholder</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Full Legal Name of Registered Holder (if
                                            not the same as (a) above) through which Registrable Securities are held:</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                   <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
                   </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(c)</TD>
    <TD STYLE="text-align: justify">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly
    alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Address for Notices
                                            to Selling Stockholder:</B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 100%">&nbsp; &nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Telephone:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Contact Person:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Broker-Dealer Status:</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">Yes &#9744;</TD>
    <TD STYLE="width: 0.5in">No &#9744;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If &ldquo;yes&rdquo; to Section 3(a),
                                            did you receive your Registrable Securities as compensation for investment banking services
                                            to the Company?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">Yes &#9744;</TD>
    <TD STYLE="width: 0.5in">No &#9744;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> Note: If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">Yes &#9744;</TD>
    <TD STYLE="width: 0.5in">No &#9744;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">If you are an affiliate of a broker-dealer,
                                            do you certify that you purchased the Registrable Securities in the ordinary course of business,
                                            and at the time of the purchase of the Registrable Securities to be resold, you had no agreements
                                            or understandings, directly or indirectly, with any person to distribute the Registrable
                                            Securities?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">Yes &#9744;</TD>
    <TD STYLE="width: 0.5in">No &#9744;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> Note: If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Beneficial Ownership
                                            of Securities of the Company Owned by the Selling Stockholder.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Inducement Offer Letter.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Please list the type (common stock, warrants,
                                            etc.) and amount of all other securities of the Company beneficially owned<SUP>1</SUP> by
                                            the Selling Stockholder:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify"><B><I>Beneficially
                                            Owned</I>:</B> A &ldquo;beneficial owner&rdquo; of a security includes any person who, directly
                                            or indirectly, through any contract, arrangement, understanding, relationship or otherwise
                                            has or shares (i)&nbsp;<B><I>voting power</I></B>, including the power to direct the voting
                                            of such security, <I>or</I> (ii)&nbsp;<B><I>investment power</I></B>, including the power
                                            to dispose of, or direct the disposition of, such security. In addition, a person is deemed
                                            to have &ldquo;beneficial ownership&rdquo; of a security of which such person has the right
                                            to acquire beneficial ownership at any time within 60&nbsp;days, including, but not limited
                                            to, any right to acquire such security: (i)&nbsp;through the exercise of any option, warrant
                                            or right, (ii)&nbsp;through the conversion of any security or (iii)&nbsp;pursuant to the
                                            power to revoke, or the automatic termination of, a trust, discretionary account or similar
                                            arrangement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Relationships with
                                            the Company:</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
you nor (if you are a natural person) any member of your immediate family, nor (if you are not a natural person) any of your affiliates<SUP>2</SUP>,
officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position
or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that
such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and
the related prospectus and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, the undersigned
agrees that, upon receipt of a notice from the Company of the occurrence of an event that would cause the utilization of the Registration
Statement by the undersigned to violate U.S. or state securities laws, such Holder will forthwith discontinue disposition of Company
securities under the Registration Statement until it is advised in writing by the Company that the use of the applicable prospectus (as
it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure that the use of the prospectus
may be resumed as promptly as is practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to accommodate the
needs of the Selling Stockholders, the Company is providing this questionnaire to the Selling Stockholders several weeks prior to the
anticipated effective date of the registration statement. <B>ACCORDINGLY, THE UNDERSIGNED AGREES TO <U>IMMEDIATELY</U> NOTIFY THE COMPANY
IN THE EVENT THAT ANY OF THE INFORMATION SET FORTH HEREIN SHOULD CHANGE PRIOR TO THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the undersigned
agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent
to the date hereof <I>at any time that the Registration Statement remains effective</I>; provided, that the undersigned shall not be
required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">It is possible that a security may have
more than one &ldquo;beneficial owner,&rdquo; such as a trust, with two co-trustees sharing voting power, and the settlor or another
third party having investment power, in which case each of the three would be the &ldquo;beneficial owner&rdquo; of the securities in
the trust.&nbsp; The power to vote or direct the voting, or to invest or dispose of, or direct the investment or disposition of, a security
may be indirect and arise from legal, economic, contractual or other rights, and the determination of beneficial ownership depends upon
who ultimately possesses or shares the power to direct the voting or the disposition of the security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">The final determination of the existence
of beneficial ownership depends upon the facts of each case. You may, if you believe the facts warrant it, disclaim beneficial ownership
of securities that might otherwise be considered &ldquo;beneficially owned&rdquo; by you.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: justify"><B><I>Affiliate</I>:
                                            </B>An &ldquo;affiliate&rdquo; is a company or person that directly, or indirectly through
                                            one or more intermediaries, controls you, or is controlled by you, or is under common control
                                            with you.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 15%">Beneficial Owner:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 25%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE EMAIL A .PDF COPY OF THE COMPLETED
AND EXECUTED NOTICE AND QUESTIONNAIRE TO: [***]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: none">13</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea022011901ex99-1_peraso.htm
<DESCRIPTION>PRESS RELEASE DATED NOVEMBER 5, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="text-align: right; margin: 0">&nbsp;<IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Peraso Announces Exercise of Warrants for $2.9
Million in Gross Proceeds</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>San Jose, CA &ndash; November 5, 2024&ndash; </B>Peraso Inc. (NASDAQ:PRSO)
(&ldquo;Peraso&rdquo; or the &ldquo;Company&rdquo;), a pioneer in mmWave wireless technology solutions, announced today the entry into
definitive agreements for the immediate exercise of certain outstanding Series B warrants to purchase up to an aggregate of 2,246,030
shares of common stock, issued by Peraso in February 2024 (the &ldquo;Existing Warrants&rdquo;), at a reduced exercise price of $1.30
per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to an effective registration
statement on Form S-1 (File No. 333-276247).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladenburg Thalmann &amp; Co. Inc. is acting as the exclusive placement
agent for the offering.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In consideration for the immediate exercise of the Existing Warrants
for cash, Peraso will issue new unregistered Series C warrants to purchase up to 2,246,030 shares of common stock (the &ldquo;Series C
Warrants&rdquo;) and new unregistered Series D warrants to purchase up to 2,246,030 shares of common stock (the &ldquo;Series D Warrants,&rdquo;
and collectively with the Series C Warrants, the &ldquo;New Warrants&rdquo;). The New Warrants will have an exercise price of $1.61 per
share (priced at-the-market under the rules of the Nasdaq Stock Market) and will be exercisable upon issuance. The Series C Warrants will
have a term equal to six months from the date of issuance, and the Series D Warrants will have a term equal to five years from the date
of issuance. The Series D Warrants will also provide that, subject to certain exceptions, if certain conditions are met over a certain
measurement period, then the Company may call for cancellation of all or any portion of the Series D Warrants which are not exercised
by holders within 10 trading days following receipt of a call notice from the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the transaction, Peraso also reduced the exercise
price of the Existing Warrants to purchase an aggregate of 1,728,490 shares of common stock for all holders not participating in the transaction
to $1.30 per share until November 8, 2024, which is the expiration date of the Existing Warrants.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The gross proceeds to Peraso from the exercise of the Existing Warrants
are expected to be approximately $2.9 million, prior to deducting placement agent fees and offering expenses. The Company intends to use
the net proceeds for working capital and general corporate purposes.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The New Warrants described above were offered in a private placement
pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;),
and, along with the shares of common stock issuable upon exercise, have not been registered under the 1933 Act, and may not be offered
or sold in the United States absent registration with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) or an applicable exemption
from such registration requirements. Peraso has agreed to file a registration statement with the SEC covering the resale of the shares
of common stock issuable upon exercise of the New Warrants.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional information regarding the offering will be available in
a Form 8-K to be filed with the SEC.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>This press release does not constitute an offer to sell or a solicitation
of an offer to buy the securities in this offering, nor shall there be any sale of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any
such state or other jurisdiction.</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Peraso Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc. (NASDAQ: PRSO) is a pioneer in high
performance <FONT STYLE="font-size: 10pt">60 GHz unlicensed and</FONT> 5G mmWave wireless technology, offering chipsets, modules, software
and IP. Peraso supports a variety of applications, including fixed wireless access, military, immersive video and factory automation.
In addition, Peraso&rsquo;s solutions for data and telecom networks focus on Accelerating Data Intelligence and Multi-Access Edge Computing,
providing end-to-end solutions from the edge to the centralized core and into the cloud. For additional information, please visit www.perasoinc.com.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and Private Securities Litigation Reform Act, as amended, which are intended to be covered by the &ldquo;safe harbor&rdquo; created by those
sections. All statements in this release that are not based on historical fact are &ldquo;forward-looking statements.&rdquo; These statements
may be identified by words such as &ldquo;estimates,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo; &ldquo;plans,&rdquo; &ldquo;strategy,&rdquo;
&ldquo;goal,&rdquo; or &ldquo;planned,&rdquo; &ldquo;seeks,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;expects,&rdquo;
&ldquo;intends,&rdquo; &ldquo;believes,&rdquo; &ldquo;should,&rdquo; and similar expressions, or the negative versions thereof, and which also
may be identified by their context. Such statements are based on information available to the Company as of the date of this press release
and are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from
the Company&rsquo;s current expectations, including market conditions, risks associated with the cash requirements of Peraso&rsquo;s business
and other risks detailed from time to time in the Company&rsquo;s filings with the SEC, and represent views only as of the date they are
made and should not be relied upon as representing views as of any subsequent date. Peraso undertakes no obligation to update publicly
any forward-looking statement for any reason, except as required by law, even as new information becomes available or other events occur
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Relations Contacts: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shelton Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brett L. Perry | Leanne K. Sievers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">P: 214-272-0070| 949-224-3874</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E: sheltonir@sheltongroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Peraso Company Contact </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">James Sullivan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">jsullivan@perasoinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex10-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  E +X# 2(  A$! Q$!_\0
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MD>8 <<UZ?K&A>'&TBY%U:6D<(0DN %*\=0:[:E2E"?(X'FTJ5>K3]HJEC/\
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M6&Q3NGL_Z_I'S]80W<]Y%%8K*URQP@BSN)]L5TO]A>-CP;35SGC!WU'\-_\
MD?M(_P"NXKZNKEJU7!VL>C1H*HF[V/!O ?PHU*XU.'4=>@:VM8F#B%_OR$=
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M-Z(SCAZ<9NI%:LQ=<^'^D:S,]PH:UG?EFB P3ZX]:PK?X56GG'S-2E95/01
M9_6BBM88JM&-E(PJ8##3ES2@KG:Z-X?T_08#%90[2WWI&Y9OJ:U***YY2<G>
M3NSKA",(\L59&1K7AK3==7-U#B4# E3AA_C7)2_#*V6;"ZB^T^L0X_6BBNBC
MBJU-<L9:''B,#AZSYYP5_P"NQNZ/X&TO2I%E?=<RKT:0  ?A73T45C4JSJN\
-W<Z:.'I4(\M*-D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# .\# 2(  A$! Q$!_\0
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M$GAN8XI;>6%_B9X;66.XBF5H9(70LLJ2JT3QEED!0D5_IV?\%$_^3!/VV/\
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M_$-3-<W6DVD\\K!?&87=)+([L0!EF)/)K_+1TOY;FT9N%%S$23P !(I))/
M'))X K_9_P#AQS\// >/^A,\+_\ ICL:_E'Q'QV-P5/)W@\9BL(ZD\<JCPV(
MKX=S4885Q4_8U*?-R\TN7FO:[M:[O_HSX3Y=EV8U<_6/P&"QRI0RYTEC,+A\
M4J;G4QG.Z:KTJO)S<L>;EY>;E5[V5OASX:?\$D/^";'PA\2V7C#P'^QU\'+#
MQ'ILBS:=J.M:/?\ C,V,Z,'CN+.U\:ZEXALK:YBD"RPW$-LD\,J)+%(DD:,O
MZ*(B1(D<:+''&JI'&BA$1$ 5$15 5550%55 "@   "G45^0XG&8O&24\9BL3
MBIQ5HRQ.(K8B45VBZU6HXKNH\M^M]+?NN$P& R^$J> P6#P-.3YI0P>%P^%C
M*71RCAZ-)2:Z.7,UK:UW?XW_ ."B?_)@G[;'_9J/[0/_ *JOQ57^8A^Q?:6M
M_P#M??LN6-]:V]]97G[1GP6M;NRO((KJTN[:X^)7AR&>VN;:=)(;BWGB=XIH
M)4>.6-VC=65B#_IW?\%%"!^P'^VR20 /V4/V@B23@ #X5>*B22>  .23TK_*
M0T'5]8\/:SIFOZ#J.H:-KFB:G9ZOHVKZ7<W%CJ>EZIIUVEY8:CI][:O%<V=[
M974,5S:W5O)'-;SQQRQ.KHK#]R\(J4J^2<248RY95L72HQDTVHRJY3BJ49/E
MM*T754G9IVB[-.S7\S^/M>.&XBX0Q,X\\</@JV(E33BG4CA\]P=>4$Y)QO.-
M"4$Y)Q3FN9./,G_KS'X&_!,DD_![X6DDY)/P^\)9)ZY)_LC.<]ZE@^"GP;MI
MH;BV^$OPRM[BWECGMYX/ ?A6*:">)Q)%-#+'I2O%+%(JO'(C*Z. RD$ U_EH
M1?M]_MRN69_VO/VEV8L2=WQL^)!))R23GQ'DDDDD]SS6G#^WM^W"3_R=S^TJ
M<YZ_&KXCG/'7_D8O7\/QKFCX.9Y+_FI\,KKK1S?;:W^]:[['34^D-PS2NWP7
MC';6ZQ&0)WZ-7P-T]+WO>^W<_P!6FOQV_P""]?\ RBZ_:$_["/PF_P#5M>"Z
MVO\ @AY\0?'?Q0_X)Q?!GQE\2/&?B?Q_XNU'6OB1%J/B?QAKFH^(]?O$LO'F
MNVEK!=ZMJMQ=7TZ65M%':6Z33N888DB& @%8O_!>L@?\$NOVA,D#.I?"4#/<
MGXM^"@ /4DD #J2<#FO@,CR^>5>(&4Y94J1K5,OXJP6#G5A&48598?,J=*4X
M0G><8R<;J,FY):/4_5.)LUIYYX49]G5*C/#TLVX%S+,:="K.$ZE&&+R>K6C2
MJ3II4YS@I<LI02@VKQT/XO/^"3OPF^'/QR_;Z_9\^%OQ9\*6'C;P!XKUOQ';
M>(?#.IS7]O9:G#9^!O$^IVJ3RZ9=V-XH@O[*UN5$5S&&>%5DWQLZ-_8A^UW_
M ,$5/V+?%'[-7QBTKX#?L^>&O OQCB\&:GK'PY\0Z+JWC&>_C\4:"HUG3]*2
M"_\ $&HVL\7B!K)]"GBEM) T>HEE*2(DB?R9_P#!$@%?^"G/[+.X%<^(_%@&
M[C)_X5OXR.!GJ< G YP">QK_ $B*_4_%[B'.LBXLR.IEF9X_"4Z65X3&2PM'
M&8JCA*]6EF=>7^T8:G6A1K1JPI*C552G/GI2<)75DOPWZ/W"/#7%' /$E+.L
MERO'U<1G>89=''8G+\%B,?A:&(R7"P3PF,K8>KB,-.C/$2Q%"5&M3]E7C&K&
MTN9R_P M+]F'XU>)?V7/VCOA1\:=&CF@UOX5^/=+UF[L)4DB>\T^UNVLO$FA
M7,1,<BIK&B3ZIHURC%71+R3[KJ,?Z@G@?QEX?^(O@SPIX^\)WT>I^&/&GAW1
MO%/A_4(F1EN]'U[3[?4]/G_=O(BN]K<QF1%D;RY-T9)*FO\ /C_X+2?LIO\
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M9%CL1F.+S?.L3E6#P644LYSI2I99AL%A5+$XN-12K+%>SQF+C]C?\%9?V?\
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*.$(I1C",4DO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>prso-20241105.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8qI5s7xRiXgen8uOYHxcWaCJOcP9zp5y6ZlBvGd1HbnaLycqMfhi3izAuKwW4WQD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:PRSO="http://perasoinc.com/20241105" elementFormDefault="qualified" targetNamespace="http://perasoinc.com/20241105">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://perasoinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prso-20241105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prso-20241105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>prso-20241105_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>prso-20241105_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://perasoinc.com/role/Cover" xlink:href="prso-20241105.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://perasoinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46514396524816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-32929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PERASO INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000890394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0291941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2309 Bering Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Jose<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">418-7500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<F]P<R]A<' N>&UL4$L! A0#%     @ <(ME6<J^K+[O    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ <(ME
M69E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !PBV59Q6922$ $  !P$   &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ <(ME
M69^@&_"Q @  X@P   T              ( !A P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !PBV59EXJ[',     3 @  "P              @ %@#P
M7W)E;',O+G)E;'-02P$"% ,4    " !PBV59JL0B%C,!   B @  #P
M        @ %)$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ <(ME620>
MFZ*M    ^ $  !H              ( !J1$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ <(ME6660>9(9 0  SP,  !,
M     ( !CA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&V!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0220119-8k_peraso.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://perasoinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0220119-8k_peraso.htm">ea0220119-8k_peraso.htm</File>
    <File>prso-20241105.xsd</File>
    <File>prso-20241105_lab.xml</File>
    <File>prso-20241105_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0220119-8k_peraso.htm": {
   "nsprefix": "PRSO",
   "nsuri": "http://perasoinc.com/20241105",
   "dts": {
    "inline": {
     "local": [
      "ea0220119-8k_peraso.htm"
     ]
    },
    "schema": {
     "local": [
      "prso-20241105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prso-20241105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prso-20241105_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://perasoinc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0220119-8k_peraso.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0220119-8k_peraso.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-24-094644-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-094644-xbrl.zip
M4$L#!!0    ( '"+95DXS(IU#2(  !.X   7    96$P,C(P,3$Y+3AK7W!E
M<F%S;RYH=&WM/6E7V\BRW_4K^OE.[L 9VWAC,1#?0XQ)" 08FX0D7SBRU,8*
MLJ1HL7%^_:NJ;JV6V";.9#R9DTE ZJ6ZNO:J;NW_[VYBLBEW/<.V7OY>K]9^
M9]S2;-VP;E[^?C#H'A___K^.LC_VH1DTM;R7I;'O.[L;&[/9K#IK5FWW9J/>
M;K<W[K!-233:O<MMUZC5ZAL?WYT.M#&?J!7#\GS5TGC4R32LV^+Q\6W4=.B:
M1JHI/@DG:6XL# UO];A#LO'6AGB9:NKG-MT43?VPJ>'9K49]^SXX1(NHPUU1
MVSK"#"OD'U_U3^/F?G[[N.F&[ZJ6-[+=B>K#%N)(FY5:H]+82@Q2\;B6&@A^
MK][8TP?'V:DTZ^$X"YN37BF^'JI>A'&=9] =S@DOH$>C%38,O,J-JCI1XY'J
M#6E8^2+;V+5-[N6VIC>IYIH=6+X[SP=$ODQU\%Q_<6AXF&ITT1^<1ZT<[JJ>
M;5A:5;,GU*Q>KVV6D&>XJG<4AO_M^X9O\L[^AOA7V9]P7V4X0H5_#8SIRU+7
MMGQN^97+N0,HU,1O+TL^O_,WB+$VH->&&'+__RH5=F1P4]]E ^[OL3-UPG?9
MG7ZWQXX/Z8?K6N/P^OW@1>/P]<'!!?R#@+%*Y9&=FYO7N,CKU.*NP\4]?IQ6
M+>KTC-Z;[6L.U +0PY^#";=T^-\_,M6;ZY%J>OP)(^TD1NI9L OS+@SEJN:Q
MI?.[$SZ_KL%_.^U:L_T$-&V] AP?7M>O)9N+\>'1$X9H7 _&JLN]Z\8U"34Q
MAD?/GC ,[O;AA1RJN0!0T=A#6Y\SSY^;_&5I!$2WR^HUQV>7Q@1:G/$9Z]L3
MU2J+!V68WS5&2-NZ,0V[Z8;GF.I\EUFVQ?&=<;>+=,I=('[ZQ=!U;B$GX&_0
MZBR8P#B:H/([O\]'+TL'WOD(*:12KU> ?9BAORP=J9J/VU)KEI@%BX:YN+&;
M(H12ARAA?R,U\E^9JY6<*Y=42IV85O(FWDBN&<%P^8B[H%6Y1^]14NYZI (!
M'$9Z;7?L(F2.Z]F5D%&J=YY>DJ]]$ LO2YXQ<4R.HD!.DQI93.79@2MG@D:T
M[;MR\;30S.*E@ I;<EIP^#!Z;.CX8F1PEQ'@/%>;=(]/TKC)=HXFV\B;3<X%
M,L>P]0400)^[_J'J\TX,?3A._"[;"TBEH$_X)@-2<O;PF41?"J6!90A\ G-E
MD3CAJA>XO".9<!>:A$.%KU+CXUCY@PM^+AI?+I[:/'."6&AD)P$.AXU;0"CV
M)&)7?=N-WSYY[5GP<L9,S'C(+7MB6 _,^2 ^LI/F#!N^3BX_BT;)>C&G"9:7
M,F]_ _IV%$79=YXJ6??81'5O#&N78=-:"0P&!T9*:H!^8/+*A7I#RB\IAD7/
MBF\[U#L<JC*T?=^>R&<S0_?'"$GM12G5>VB[ +SH_<I4M5O6  @\VS3T/29?
MAB.)]_7X/2ZOXAG?0"O!TU+GO_^I;]7V!![DWXD5;*26\%W0%$[H?(_A]A@R
M>T4UC1MXI(&,XBX@:]AY?W9\V3MD@\N#R]Y@?V/86?:$@U[W??_X\K@W8 =G
MAZSWL?OFX.QUCW7/W[T['@R.S\]^!!17JC<&;]"WH?]AM5MEC=IFJ[WTF7_,
MGAZ=]]^Q?<]1+1*':$NU:P=D+%8JA[86H*&!-OFU%AFRL4G[[7@^VNEUS8\[
MVTT8[ID61SMI<23G+'5V*B=9"V-_ Z'MK C^@<#[O;-+UN]=G/<O5V11%X'K
M!:KE,]^&CAKZTZS>9+;+ZIMK^CJS1\P?<WP5N(9O<$_IW6ECU0*)>*#Y^+K>
M;K96 1EH8>%Z^MRQ79^MA;]S%?0I]WS&I]!2ON;Z^JZ2Y<57&5Z\(/NL)XRW
M?*9LV/ZTU]O^I'[3GL24(OCQLF3<^;LZC#Z!MF-=G<\!6FZEF;9>RV/:%'"E
MSID]Y9,AV,R;9883%;+RC]ID7QV:'%Z9)DRL88BO!.O WQU5U\/?GPQ&PJJ(
MC 7--DW5\< D"'\B W/?EY;6OJ]G;(_0O!@*\Z*Z&1L8BPM+&QTUM#H$Y22
MKXS4B6&"8_H ^(LC#3M9,NQ*,A0.89_?&!X&S'STQ?.I\,.KV].35SN?/K\R
MGZT:ZO5%9S0]=ZEST>L?#,[9\5FW>J^JD#_Z.O[E%NW%#\;T6N\.EDH1#2$F
MPK4QU6,#AVOH-NK,L%@7K'J 9CUW(1M$V)U_L*",2"ZY#SK7;)?"L;LLL(!'
M,%A;6J#-K11M'ADF!P( L9-/E^K.[:>3/T\GIR?Z\^FRL4B7\;P4 Z@T&^U&
MNY B?XP-L]:U)Q/#P]P&0_B8 '!]*9-^"3S?&,U71.3*"5KM%S^#^'V5(O%C
M"_C"D:PQ\$'7=D4HOVOK!=+8VAI^/=1.9W?3IU%]PB; ) I&FGSNN/84R7_!
M*&@NLL6]L(*!Q$UU!N;%(T5W=A_E+C4>NTDA:>8,]<\FB4OU[EB&&35"]7TB
MT/UX<M8/=/_SU?#Y(C G3EP 1*FSO5VI-=KU=JO^%U2T_&%)DI)($UV4<W!-
M7/86/!-/-\AW(4FVQ+E!\:>XA,1S+HT^E\:7B[KC:K\ZJ++>Q#'M.7>7C:XT
MB255VLH:13'7[Z2X_D#77>YY\I]3L([J^1S?__II./I<-V_?/S].4]]<Y/@<
M $J=1K/69J]@;.N&';KW6^4_J4G9RD-S%WX\=R_MF96/9%]K#,\T;="8/A_'
M6X4XCF<O=08 [%M[,>TG45M>B.CEKH=$WKE[ =K<L+0"P^'HQ&A_/M_9M$?+
M-!RV"Y>= ;+4Z<(VP^"6H1:L?F'Q6WF+O[ !(O.SX13;3%=.;?)YHGV<G_T%
MIMDI7%D*@E*GO5EO%JO''^0O2-#0%W6 ?S7#44W&[[@6^,847500NSCDS/#'
M[)OA*!K OAQWXOO*V0?R0G]5?JP5R6GDV@.7J\54YC5.ZN\_?>J=GQC/I[)4
M"#TY9ZG3JNT44-7Z J>T)=2GMJ::%V/;NM>3?M\:!<;[CP=OKUK/AKR1BB-F
MYP7HZSN5[<U:[>]FC#@R\]__[#3JVWL>M#.Y@[ RBX M,V 8,T"?5@&/1F7+
MXXU\5WM)<W3''#PA#-BK#@APD MH*0_M.S;DICUCAHCF'X' 9SN5$V5DF*CY
M#0_PX7/@$1WS )XQ"4Q?M;@=>.:<><!#WFA./64'>P@3"YM.)@C<.!Q&O,94
M:QZ^&X&+;\^P'RH5 T,<WNZ/0$=!=",9S<A&.Y8CL]*Y;-\-IYERUP?CV PA
MAU$*EJ(L>M(UPRIM='*>5QN;AI4>Q^2C[^OD9J110TJC*]?P@9 PEA58TNSW
M\D72Z5>C]\;29_W&\U,?0]LVN6I1755&6*7"T;E@(7VTMUNMO8<$%GHJ^8Y=
MM#W?#[,25-#625B9D\C385$":S4V):>E\W.4EENK;[/N49^!>5^%AJE(M$)>
MU[)<KE^\]\-YKRYY;V";A@8T8-V\ ZD/HM_,9SQG$O2V!J<?C#<[RV"\5+Q]
M$::?D^MB.)6)!'21Y>HMM5)O)+@NE0J/>*Y5JXJ6O]ANE=EN4[+=A<M1KV!E
M*Q7#H!GEGH]&1::XN1.<7$Y&?T[?J<M@OU1<OQBVGY,- =Z*E@#X02U8;^F5
MQMIP_7%,*=K^8LM59LMZ/EL>>U[ W0>9\\K>NAQ/9Y\NW:?%D1[)G*U[F',!
MPE5AT2:OM-:TQ[&H;/NWL^B2YDB8Z<)AYBZXW$Y>#1Y**D4ZT("FW7];'4"1
M8!+2# 90M=L;UP:BPD%L=Y?-QH;/2\])%F/'"JZ5X\F@F:LZ$;3-1^>KOQ^+
M7>+!.U%ZJ(V99JJ>=V]B_1[P?U"V_6=#H*LBF;+!?#*TS35O_1?ZGH*^L,2-
MR(^'LAJ$$@ *3V+)55 &<*]-L<BW_^EV>[VCHT7._=&%&P6Y*"FTY_7&D#BS
MH&KGYM/LLG'1V_3:SX^PI]*VV7E+'3078!L&OJW=EIFCNFRJF@%GO]6JM5J=
M.7CD;7Q?A4XQ%_Q5*O^;]RJ,/TK.%XR?OU'S2^?D?/CJ7?\;?_Y&I7*_J4G!
M0NH/SE=_!R[!+BFJ<PHI-[3SBBN//_;=*V?SH'OU^6GE3=F4-4JIO&QU8SN/
MHY)PH;CS=/5K48::F(V]4]U;[K/3T^Z/+.K]H;;IL:6C$<_9<,XTRB-!KUN0
M^9RJK-))'L7P&&P]>  X\ T#B3[SP5:Q)PXF?E2/Z7QD6*(>6L2K:YN+ATD2
M9TB:D2. B]W>H]!U;7,=Z[R$']$85AJ//(^2'0M="^R^7OWGY_AZ!3B_OXXD
M[/6:.G5%GWR>G)QL3S^8'TQKLKT,'SBGRB(7N(?=WW_Z3AZ/[N$A3%%G&%(A
MAC06$JYC8#=N@N,([&;9Y$8&'J=6,*U,Z^*5*0:YEN+8.&X7S67.<7*J$D$R
MLF!%\,;E4\.#?L#$JJ5A.%S5Z!(2#)'C?36ZZNJ>2.CJ13YL<TV-3I EV;3*
MHJW]I^_AWWCJ.7&J.??4<^)4]-]\ZOFGVA]<UQX,\37 $!;,1(LD8VH1W9ES
MY$FO+;F=]4;.?FZ1P>6DMY^@32Y='L%?F-_EZFUER(%+ 4:'8$[.N)4S(4+Q
MQ!F3N[XB&S[L'/M\ GL%'E$/3R]@;8O-5!9F(-DAFB8&5LDI!S<NIS!F=6EU
M23]T]><6RY[D++,+NAD)"]>K; UE,=9%-6I[4M'2;_6]=86<!C+9 %^@?0(1
MX<520AC.Y+Z/=3TAQKS46,=Q\U-JZ(7#"M6B<==7P18<VR;P5;KO&_$L@@-#
M#W>@W"B$ VL'I+QB,]5%9>>%^D0"C_H&= _H%M!X@8._@DY5;P#*&WF MU%N
MM+;*M6:-R=N$TB-$16*:\*Z]R+M6\KUKMA;C+W+'0^#+H(VG"#A 8;L&;)BH
MRG0U4*=8J*D13+\UJHW->$A0]AC]I^HK!$UB!&,N1WSH!JH[5W;$=DI-S<#^
M=1';_,XQ1)4CT^6"(PH(NR21W0LQ>R41&D*^ J9Q\C [+GF1*,M)]"I$RX3T
M:(?(*E*],;8S7+: +:;Z@'S@$AA8S]O8>A4(+4$K"=3W9:^>[*6S"^P6T3VP
M!]C7'MA3<D,1F#Q*C7@002?*03=+12BF2 ,.:"OQ?LU8)XM.LE$W1>0QXT3,
MA> J$MRH3Y924CSW&&Y+,DH*(]DIF+C?)V(F!>Q,6$-Z$8>/641FAL-H$64Y
M.,.A,>F QNJ4FW/!6,*YS"R\K"1&1 I=.D8.,Q@)H5:> '78E>4#G\6U<-H]
MS36&0)FB7C0)&>4D@14B>:$<$[U:TMJ/  D;EE-R&CQ!F\4,)SA(^BA9)A+^
M0I;SBG",^J)>WF[LE%OM0APC*ZFF&>F?PEG0@0+9[QM84$^O@+62RPJ%2Y:;
M%6+FB&==/@%]1^VY.RF<;P6D+D8"-=/VJ#!8+).\3543&6&*&8"?J?H)/U$I
M%-%8C0Q*3;BST,K60-6A)L0='-J!'^NWK=#"\8+A%^A Q<M4K2SF1G T !-6
M!F9@""/ HY,G[%65RP2%BDD]09T:QT,4,1^#<^Z1NZL! 1/Y4(7UG8'E8L"&
MH-#;;&*8)LEMUYZD2;N0W(945ZU(C51FPN('1@2T4,M8EH-Y#G^/./=(=MD4
MEHNH$J&W/'CGJ'/*WXJ1P]5567*IHMK;2T8*+.XKT?*0B&>V>TOH4AW#1_\?
MY@0(0#>9+#P!R7$_'1NF71$ZCFC!N@%TZ^Q4U;DU#-P;0)]JPL 6^Z\Z<?:@
M(<J_C$%]$>W5 >Y54CO@U1$@8 T?B5LS P_)*[NW1KY 37&3%TQ@,>#*Z\@-
MX,+@OF $*):M0 '4+P,.&HUHV0 %,?!^81NA[4ZU]B*DS@R-2R;08W).&.I@
MAR2I6RDPETBKS#@(7H00ML&"E4XD'<=0U!-0^#926P:6"(18N3@I8P_,,NEB
M*&+O:!+ALY21%Q!-0^[/.+?2>@F>YR"K3-:TCF #7(> "I(X+9(X35J6.A&A
MM91U'<VM"'$6:4N6-4[CIE+R9?1E0E4:$R!!R:?93456%50E^3]%1,J"5B9+
M$?Y,,)@G/:;?6IOE6JV6EA$9A2W,3 E[%@@) Y@/P%(HH')ML:B7(GK=:T4)
MR+83A!$+8W&(!Y\7:'OI33D/^@-*QN&:C9-KC@B\R!FXA_D+S"R!XTQ;)1IP
M9J"-HH)L )6&85;? *M%L+.':7DT)CRDOGQ#%84+!QE'#)&W4^F9AI&*0I6A
M8'C7E.=\IKR"ETD!K5@&WKF.&E1N1.AG(I;QXG+BH1ARC&FG3;J8SQN;T79F
M[2?A#*V('DFA!K9?-2,;($NRBB!9<4*18O'YE@+*^"%*KX+*,4*[[!0F!TB/
MT'%>$<BQQ-&O0:7.UL0E,W:5-9O-2F-[J]':!H=+E'C,R!?03!4GX2 YR-L(
M38I$_@Z7%T7V$S?8I%R:7C?B\$1 ([3>5F3'0[&95L4C1+*:V@\EW@^1/<$-
MB[V&)*DL>FN9> (U[B<W>Q .G@J_@<P']U.#UIBW 0:>>THR4!2%"DD;"J.0
MBCQ=3<@?EZN>;9%=">1@N\),UM30>KP7%&PZY/D$19XU4$@(YE8&3+8&F&EG
M'\H<&/8#?PTOWO+204$4?X8OA!*FL@"1R:19FB_6XQ.*2O*0HYB$0L4@ONY?
MHD3<+>?.(Q 28P##20"C3T08R5]%7#I(*FXV!I['.$Y23UDV,VW@.6@QLRAO
MEPQ+H#[.H1UX2K$4'.B0FQP4@L[HFL.U=,(^K2NE)>/]FR*$DI#""*',J@H;
M"+%=8'< AE._TP<3D'+%GD0" <_&DOM6(*CCH Y0^!K:M%0)"G91RM<-@^I"
MZ:-[L![1D.'Z<[;6K*T+CE%'&+S/,GS:XB/1E;#ZY*H%L0+\ AN)1]CI S@C
M)!?Z2$B7L:MR/U&%Z X!QK/98]"!*!_ 2+<0^'H#H$\S/BU#R2Z#K=V/E!4@
MW(?SF(T]=B[6NXM3R23\'FR0&?S -.?CEYU7L/:(''FID_[*A%C_'L-;B'?9
M@:L.#2W\\ 3BZ,S&E==3J<ZP%Z7H?R5AEY&$O21'9=&0\58CT;IO= X#*;>%
M$9ST8O8WC!588P^53M*.>-#'0W?ZMWIU*Y$M%2IF,3F1XW^"SP_8C%RGV!OU
MC+L*W7#\&&^4)E06\CY/FO!)[J]8808=2!,B3$&&]J(Q1KTC&+*!XI0U9WA)
MI9^\V4/5<;,F,G9($>>IR-C+Y)CX-(2E>V5%// <T\ X 8872 CZS#5NQI17
M%P$B> D3,*!M%;J#<6(, U(K9;!6;/=&M8QOJGP -HUG3 PPZ\7$J*#)LI5>
M;,H8DI$V)8VI5=#-1J<7$A6X#OY\-=C_,DN'.1Q49C+.9)/IH82G1D2:#6L8
M,:1FTFV-\#,FUB@:JW,3V8H*)9@>F'-Y<Y6P.F4:,"(4+#U$$Q7O5X;.CCH/
M27X4 $BA\QR%!94"\SP,+NJ"Z;R SK?(2=9DZ$PR$AK;E.:AH+F)-VW%\'C(
M&5K@>6&F=+W*#N2BP46W;ZAF6@1?#<$50!C L6#O3M0Y6=;Q:&!%XYWR,F%%
M4(FAHH1_:ANDZT*EG8E(GYQ]9@>F3E[A!!-)\-I26M5V^P5ZTM%V4;EHXOJ>
M<+_:V#*JV;0#GTH]<9O2\=7)A.N&R'P)SR)<33H"26@&-H<-$MNJ1(%\":Y<
M3#<L>DV\0D09EH:A!Z(?G<N?*1@LXM< *"P5Y//8<.B7!,1"X*7 DW))N0^]
M(O!,B CQ\&"\.3GM(FYN#*H(DDY3M'T288KJB3T'E8EF,!J \9H,]*$PZ!NZ
M4<@+KD[Z*DX0%=E:Y;A E_9#Y/XD&HF=D1*'/ Y(R!@P:'#RM^*KFR1;IO=K
M-81W-V3PT(A;#?E]/(K8'<-+(,DD8X6D)]*1*7I1U**01!AU#E7[@Y%*&2R6
M<Q9>521/?RQDU.(JI&3S**IIB$H-'X-C<30-2P2F*M@CI)KH);",:?  YYFH
MMR'TE @-]0B%8F8&Q3P3I0H4M50FJL[SU 5I,]D_FY]*6S@+0HV$+\//OG)5
M3Y8;Y&HE@U1)CB)=+X>)^X<%5$*&" $B"UE4.K41F"KS..4246%9"W)DR7P.
M/!@RQ+(9#Z;J"WN7$M*$';$UJ\'T/:%],6T=476D W)V5@%Z DZ=&JX?\+0U
M$*G'E(;-)[!RTFQA:8\'-)C-!;N2[TC20_H<+M4L&AB+IHR$FA@B/7YT82,I
ML:DM\EPT3%EZ;DD08AGWD#TEW+<43B3"LK95KHK-K$G47X3E8R0F4DX4&3*A
M4P8M#1US8OE(70WM>@2B'P4[5G4DPL/>:O ;GN$2=A7IV 7JP!K@A'4H*DDC
M:U<(=R (T  ^V(LDW,/?R'O"N#@\)5O>Y5(Q)>N!A/)#65: Z+PX/( 8U1Q@
MY6<1XT8>GT4?@TXJJ_(C+6.9] XT#2PL6 FJ:.UK8+BB%"^Z21\%4;HPOQRF
M^:*J-4^.Y4Z%19WH+E*75+>BB^H^*E-+5E,+P"GF0K(?P W,2'LGL*<DL8>E
M0PGT/&K15#Y'B?1<>DA&H)+>@G"4I(5=  _XF73R5C5!H5NJ3SM!2_=S13>Y
MY0O!H7N(1>2ET&W$>BWN4H[1)51B0D -W?SDQD2'!P?!$!!N4+#,90>AUXLY
M3)=+@]"+5>["80[=)C5!.4VLWE(]GZW=K;/-6K7^(L<K+7+TJ6Q\GNDG=89C
MS^*MC&F)2'R>X[V1_BA Q'HY53^3E 303A[1D$7:%"V+D_%Q.DMP$HZ+I7U)
MK[QXDUQB#A0'LGL8E$3+V0F&IJ%AZ!)\Y.@,C[!1'0=>$>45#+Z>+D,#!)MF
M7)6%KP(K5*YZ,FZQ8%ED77T1N4E44,OG<34:ENNB81[5"V$KD9,::&C]>B*;
M52#2HJFC $94A*T\$FA4QAET+NP,$40!]E9#95^I%/,F-HH^8;XB"GLAJHD>
M&:BXB:V+#[BA@A)^*'(LZ>OXVNI<FIFI5"8;A6,6CNO($M-QNGQV)F[Z)?H2
M)Q#_Z;A].$G=_)6/%OGHQJ]\](\.\H$>NP@9F:TM) C75T>^+28_T>S4  ,Y
M)T,P_BS"O-XN&G#%=31H<Y2E592LC(N"54FMN7CP+BIB"P_B.-&!*02C4<.N
M6*:(\E!^Q<27-[F)4L!$[>,[L T#5]@VXE.VT<$^87D_-%QX#88P<,+@A!)>
M;:G+F$+"!LQ=[CKA!X\H_-:J[C13E4B)["PN$OZ?J:XN2X)1P4IC.$K*@H<B
M#MM$&58ED\:-=(EIW/*'@2O'!7^P.!=Y65<-$PUM$Y.V4]L,)F(+:)1%K(;+
M4W[;K-7PD !E]I-XE$<TY31I3VGA-*,,VV($T_8\+HJ%T2&AQ(2X0<8@&PP/
M=  &P"@/?"Y2S1,,L"CQTS*+[NJV;*LBS=[D,'$U<Q0#2Q-_.?Q.!4;"O=![
M,>2$\3<L#%=^4 <+!(6#;L./"A<?4L/V=(2'XCMQMD_&H),&-9@;Y= -J*<0
M*7&&19FAE9E#Y2)(G,K&+!0[1)E(-3KJCT1^1IWB Y\H$.2!9PMO]XPL7'PN
MEY^QE1<E2^3K*FI>ZA9K"G''Y]P7U>LR\\O#"VB2'GID]R>.W.<?B*VRX\@X
MEX?YX@BV(EV"A:X1G=/*42:*TX)&\I!3>#U.^'M2J"70"+^[=G S)OJ/@Y-1
M*ZRK59)^BL@32XIX!&I3AQH1Z.3D<80A%^L9H2:/#<CC7"$'A%!&41Y)!IR"
M"5N[>(Z].JFR-=1'GVSWEN'7BLB[70_])$Q!C]/B(%(/A+@,UO#>L"P@;R2Q
MTB*I$PDYF"9U=#F"=X4N+$!EC=**_(J%XMCR0ME4>9'5$5=%1X^0PE7?5[6Q
M.,G6NQL;0Y1T]5JU7F8M\5>#QFA5FZB /"<\62[BXN)$N.,GG1]*-X<QH*(*
MZIRS2?D"I.  7MIV$4HC_D31D(N[J[@O#D!B&Q0>T3>XA<S&H([+@6B'>(1A
M!&+'$E)3)MD$.L1*<TXB8SH03:#X#+'+'< 1NOW2(I('W? B.G$T?\JMQ,'>
M.$0F-!% P"BC:%N@A</"E? 0;23W$Y>LT.K$&_&-<8UX!*?&P< KXHF1AMP"
M<>.'FT.9".Y%*\Z,*UW?A* QC8DAUQ96@9.^D:M!A+BJ/)@LQEYV:G 8,>*R
MRT;#FX.:U5J#O;<2QZP&JBDVI_<U0!$8YZ17Y-J@;%"D7,B-Y63N($SUWR>#
M9!/*DHEBD_01ML+" #I4B"1.A8DYISE!VTU$U1GIZE3=0C+E&5Y'UUI3U]<:
MZX4SBC@ZW36Y6=O"CTK *)/ O!%)%PQA4]<5T3L)R9X;U5J0RYE3NQ*/\65;
M- CH]_#K<N*S<M%5 7I:"",ZC>\6+UT.V@P+OU^,W['8W)2?]@XE1#.^3NP=
M10[#[Q_@9P\H*XTR.+QP-CRWM4+B @L@P8\/4 =%I2,%)*%TY655?8Y&;W0.
M-8](!%VD:84N)"/:BM$/;>C8N]3P2V7*##DTF]7MS73X;/E::0?Q*3YXWJ-2
MZZ73TM^YZMQ[[-*Y8#KACW=><<]37&YR<2\0Y;Q"3RR5*8\O-P+:B6F4;M'
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MHG,BO48W.=+A% RS#?E8-4=A&HC"?+*!"(M#'QI.#?RQ3;>3_NO\X7L_R+8
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MJ#:Z?J:AX[PX9Q\Q1D?/09\)*)NI-I=+%-V=!&8C_!>LQ:DER;H*XI>N  7
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M_<8$KF)*9NH:(O,"Z,[:ERMP"J3J0HAJ'\ W0\S)*-Z><HM$#L'*&LQ\:HI
M4[F/.V%@+6%@S,) 6(S#/^%@1.5KMU[374,J:G7%Y5I/TT$$7 QJ(0V2,#-T
M+D'\B 1ZRG 6XW5^2S7Y[PYOK>6N8-M_>F?;]VW[3W],V_Z/<!\V(B)F?;'3
MFNH'3H$[2\S<9/#*0P4U;JG8;4RY:K)M&.N'8V-J,,.0$9:*X%B!GTP:@32?
M7,FR$7BFC69C"J:D>88,W?;/O$K<U.1/.MKT:C8+M_PX"TK&(%'::BVN/<):
M()0TJ/Q#L@_E"THF=W*[R'@@N<&5(S$U@0GZ4N?T4K-2P[$&IHP&G4&RD(%
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ME<]UM>MI%*8%%PMP#Q6]XLV'BMJ^J/K:%A.-I8[D/(WY8!UC/YS<19B/*;+
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MEU5I7E1FW+?:]=!5RY"V6[5:7[JK-C6KX)X[U?9+?OLZPRR .<Q"W2 L=WO
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MS-__M8#)"JYA3'.T#DC;PS59&HW2#,WFL1@5_1Y?RA:'^JMEW7,,(%=8/P5
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M<7V;+B4?_905HZ6?G!/D[UZ@ 'H:-<;>^=5"G[RTH:Q/9!2!/P/.)2)<MJ1
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MKV2[,P,6[UH7")$9I>1*''VHILAY*>B\;@E^PI=A$X&.$HUC&[]=]U>#\QY
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MBA"%?&$#31J+LPTULX!.WH!ZNW>L6))W1R@UB, !U(O&+]<B[:H?HMKFMVB
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M<31+D3#% _6=17)T'7"/D1V'P&D8A0[7,W)(KIK<2A6'DC*J"PO 6\GKWN!
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M(P:KK1+&4E6C+WTSUNC"=N1*?RY6S1?HVEN4O.#1Z%TA;V !TSKZ2#F/Q""
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M!-A?6TI7M<@P(E8X6A.FN?,9HD% A1"W72>P:<M,.UM6DOL=O O9(N9Y3'#
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M:YR6 RS^RP).[TE$D8:J K5F\(:R)$(9RI@C91(DHT=83%K+-%;7J*9N;><
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MZ_,4*.+!VW @M:SZU!P2J?"7N82G#/LJM;B=>A!'626_04GF90),6Z_ISQB
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MH9*G-(@DHI15$D<J-(Z8JN)0)?CXAZUC6+%>O19T6L11GI*VFV=CQ-#%V\@
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M.MMZL=@U<F%O>*P<K8D-M]_Q'JW4,+M4T[O;FJ]KZO_;\;_/LI ?CRP9CNX
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M(V??HSW8)F3P[+Z 1X#1E(V005Z ]B.]]1R7HJX5G6[*<7;(H9W'+<?B1T?
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MS!&XV1!_Q9!4[H*3<*"5@:(BW,!N1@%0FH08GZ;6,A40'5_1G_D>6Q3$U*+
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MT,X)!"M?=T&U2R3#R7%A.@I.N!#71@_DT))33Z08AJ$ IJ5(-&^:6NO._XU
M^K-U(-T/I#_[8P;2OP^&MIW_GYC._SJ#RPU"K=OU.IW_E4# [ZF@W;8PRVT4
MPJ@V;9 $L?7@G*ZX:717&H-ZA% G5AS>J#^S13@$3RL@&FENLDK(J^CW+)YG
ME7FU!3FG4CC MQBP-V)>5&8QWB'"DJU3"E*$:D:C"FJ9# .F8R6Y9UA',J,(
MS<1'F:JQA^XU3K>YSGA0X#4W"O&'35KLGFDFTL!S^&$1!FH2='T*BK:*<!!J
M((B!\9Q[48WF50.Z)TNB=9 Q"D*FR&+& 3!,U,F#4U>R!:MQ]0^JZ*,S)X&A
M8OB *<.GU-[3ZP6>P^ F0]$(/<ED8@QX[8?%$-BVN(:\#ZU370[PVN%4F%*O
MPJ"42JW 02R"":P0<6/V3N3O):6W+!>'.NZ.G11IG"^Q&O??98NSX:(',63G
M=(:QC=JY3:X&0.B2O/XF@DXT!G9';1MZ2V6N[S)6'[;9_%YS 3Q\& YPFF('
M_,ZJ5?'7&L6K#8!&+4Y"_'*S*(&6A)G4[:[9>OZ,K4#B-\[-$8VA;Q74@;*3
M>9K6PC<M*[.LYA.D]FP#>L::CHW=@5O,X)27N"$*YU%V,*IW=.E0UA[$7^L<
M00=.QR_$OI@I;DLF=@J6(80_252'&8<ZT,O6S!&D%?E)^@\X42AM_V,)(GD8
ME:(W$576^OS(*=&UII1N__  *VG8P+ARF50GK"4<4Z"P 4U5D5 DQV^,J")E
M(W-X6=9(3$1'7:"U6&)!7*N6P;A!ASK1F"9)JH69]QI-Q:GS!9HY4L[6N_$[
MY@*0U,R.=;V" \9;%(OG4]9-"&L#1(/0&;9KE(TWLHYBZK>.P-5)%9;$&NKZ
M//T1N.JCAB^/6Z^3R&;+3K=!^KV0%"(X[/,8=("!$WGUTNV&5-K\SMA,44X$
M'&80:#:44C.B;'\-U"L5BF=G8+31.B:^XF5M6X!MIFV&#36QZ;$6$3+[PHA7
M39&HF*BS9:$I%+^ZF60"AY&5R3 R)^5YM79LS*!19=(,M3XWK8NQW9%:3"7)
M!:@Z9G'$18$T:2.G/_WWP4.*41>V0K!.3&[%SXS'IK*DI;:1Y-R0LF0QM[ U
M3VVF4+R>'7*91IQ;&DR[ ^HI6H0IQ8IZ:RB$*<2'$YAA5,TI ^T&*]4 6G.W
M])JWOO2%,\G=ZQ])@;S$<E2G,]65IW:+VAH=R1O?6H/*;Z^<D%I$U*_#ASZR
MQHE%>RZCQ9\HM"Y&?:4^KHYIYR_=&E;Z86U(S!!K*<H/"W:-%10,:N@ZT=(@
MU/%I; PQ3!]/I=<^]OK9S">;=$'AD)PTCD1*FRD(K%PAP[PY3N=B#G?:>?*D
M&;65G[!?9)UW.G=>(;QM=EEOVNXD]M';JH5ZVP"%9H)RV;";X<DST'2\ BS*
M*>.45]U2AV62=OH;!Q:A%2:P02U5;S;+[B8H[*MUL6,PSN-2^E#S- ./B;I8
M9RU*]F*9G.5:OOV>9U5:I:DR7+[F5I[&#\IIOH+<B$U;B]*A7A24P[7=YNH6
M4MAL!L7A)KPSU=SJK K7$*Q;0\V&?MP9$.UBZH\D166X/FT& V?L-@$B<_=+
MO-JJ,(RF4'=.[(EJSEWMZ9K^B(K*)%-!I-XF>>J5VM9$E_S,C=_5Q1:(JE"-
M0I4=Y$"C&"I=@4J6*J( XO%7X/CO(P:]0E)E9WN=5?&S*CO;Z[3*[Y>E;5KE
MJ4FKO$U*#"<R0F&=3W'R*:>Y&7L(!L^EQ6X&[VA @V:VX13@>,.J2MG:!.%]
M&)4W+7$E8VH(/,.UN21P(BUU%4FJJ*V2QLAQW*DP:XI<1&E'$:+B9GQO*^K(
MY3S>& _ V Z=6(('S:"$A?^3W:W@O9O!D4"T@;\AW,V^HW:XJBO!S#8%1I04
M!91UT5K&ZMB__9Y=,3CLN7=O@EE))J)]"*5Y3?^#6YZ1XI4?<BB=G.PL%X +
M&Z65V^*B%D3/@+BTC)+XPBM^KQF@Z_,F4=DW>8D8*K 6)^!C'*&7--?F0<%;
M,*>L/>2F?[T8QBB'#;)FHT9AX@165>^!/S%-)+K*U\E8LN-94EP@_@W7-_;7
M-_76YW<P+"SX&S1P43&D3[N]VN)M_TR83!:Z611S<9[/V2RS@I @UD#4:2:%
MOZ:!QI)F(4EE1J'7Q@@[JVD9A\[1V5E>5I(OI , CJ:4?=>2K_B1)*W\(GF'
M0 WB4 I%B*H=H&S.!]:# ^RXNT1G,+A)<21B\@$A3)2SR\82C76:<[DK);JD
M23Q?:<GK@ZQS@Z-J7B!8/$3X049_0Q60\-_B:F2J5^A8(<X\IQ ,5J;'8VJS
MI&'#RF2ER=TQ!XZUVBPI#$\9I6,E<5YPC0BVZI.<J!=>BKRV2#+JB\N2^$&2
MN& PN'9?XH<TLG8"FLR +MSAB.=7N4]8LX@$(/=-?;XF,!^B"O&;$^?35M"J
MR+0];1.OZZJ,QOC/BJ5DP7/-.?1/Z3W;&(&#GY*X\AL+N1"2YG1G! EPM,^<
M4G_\9,.\,X4GKA%$1JIFM,5:;/;*\/6[M"E%*+RGZ!-)P;6-P-2Z&H,$IX2]
M4J(255A*<K; R1HY94UA9<6U6WXRGC.4'9\DF]'O93%VV, RH55>VDOCK_C2
MM),5#6Q-4RT.,%V[M FFP*J'*(%T1=+D3"=9M(6?-#4K1=.EA=*+P#3Q;#<@
M50L]I=$=S5XW&..0_141RFX0NQ5[S+3JF#DC*TPQ6#5>:NY%-B,KK]?O^0EH
M?LN5=\;$)#5GY[8(2Q#&0K?ZA-M(@+26W]7.@6;89SU"V8$<P70R8L7LJ0ZY
MY@(19I+M1V9?:#]>C%MF6(=7EISKH)P:1OFYSQ$QVD>4:6#V9!R)Y6-0!B-J
M'=E(7MK)"_KZ@I 25W.#O5;J@L_0,_\7< ^9WT/1^9&I&P6Y&T^Q7$2+)VP*
MGI[PI4='?V_JXEA<]$Q[ZV#9%)7'P"F^BZ@=L?2G8@[&-+0;G6]#Z9%AM'!L
M+:>=>0=4$SB7CC+*4,<<YM'1F3\7!H%:^?Q:*UG]L4ENBD9K13M*GKR*S.;@
M>C=UQW5"S(2VI--,^\ V1NPPQ1](7M('2)A\B+I31\"!TJ6\G-.;3-@=ZR'*
MNM*!LSD7'<R""7B<V &8_SH'[3V)*'E0EB#6K/M5%(3R01ISODY2=?0(!]GH
M6,5ZC4Z_:M,#;%UK(06YM=(UCE/\)E2C9:6U\) OL*ZQ@ H;R8%0*:AROQD!
MPMM>QQGVEG+JOS"^>YT3*WG1$Z(3)GG%RT3UQM&Q653XO7'K[0=HD@:EE+BD
M1'&M)'Y0GC:3.LT6>)P580BH/)RAQ/QLG4'HJ6#M G@ON6EH63&69O.-?*W*
M:VK'E<;7# \FEEXFNE>T-FJ*AELB8X$Q57L5(T8C.^9$/,%=+XDBW$[:>651
M,Y&4CG+.R.2Q6="4VC)OH1EM,0LPZC#,QPN%*/X*9[0<<R)<M45HZ1E:@M)B
MXDSWU9 /V9B/)1MP3D>V%IOJCZTM5LIG[:SS6;5\ULX?,Y_U7;+X =%;=2/9
ME2*DV0FHSX1'T+>MI%0471=F<K79;KD9Z>X7/K9"6I?+5YN5IW\9">F*6H%M
MAJUJJ%L.@Q>"@AAQ3?D8S:0E(GD=LQ*DRT]@:109536_B>XXA(D88!KBD,C@
MT1%?HK!#)T*OM?"@-A'A)>WQV:8#(08>8M6>/[ STV@!4A^ UH(\0&(Y<MMZ
MG8&)7M!C<*8B0]@$55))7!S)]TM>?+!&OFT.7=E2J336 3038*F*A^^B^Z_<
M$AQ'5 =$TWNQD[GCFY-U@Y:GQ$8;%/,I439)A0T),NMHNV-?B1SH,:91F[MN
M1R&3 V+-6.EKH[57'-!*"G51,:$8Z52U,K1%QZ$)&(4<&).>$G#2\889?3&-
M49K@B\"Z\D4L>!_$V)<#N[-2>@_+IOYV)4_7U0E,M$7DJ,?8[1]#67,PT8(R
MX;9;.H]*#&W=R:U^S]D+::F3%$5\FX\X'S0?3I.JM#EB>;0O!A3_^9FK"(.#
MG"A._N#;*+O!:C?;604E\%A:7*B-CX.VYY7;_YO%J@,SU1B(SF"SD%,1^1XS
MR,LS.&LT!R/:) 0X9=5"'?*@)0LGC"RM6M (+T2#(!43A$2:Q(1E[U";1"53
M%\5&0TYH4"_:WM06VRW9KQ/?=,$F>H=.)*_[R?@8<,^H HEH1Q5.Z(QGMW%&
M85WX<Q[;@)/][;ULPX0QKX SS6^EJH7N4DK8R.BHW'S./<PI)#VV]%OZ*A0P
MP\Y&7-4TRF>VY\AM$M50;!)_@']0,R2,09+0Q@-O6I90^WN;_,5. O+5P+3+
M$0$F!3S<4XDFZPJN% G'(/-24JD=;9Y=&<BO*N1J1*4I+,!P6!-\;Z<M-0U*
M1K$5NJ<Y%_Y)>Q,;O;5E)Z95)_GH2OT[J0XU(Y$Y7Z /DZLX>B(S2\VT=]H:
MD/V4R1.D-M--WXVE&AE:H@5QHVN\2KX=B7F_36)+3(4547PK[, /PWXGCD?>
M^@P'1IQ,A_.BM'',W%GWQ)'^-L NA5"ES$D! 2CE5SJ&I:QD6[#)4%92E(=0
MW6-7^]ZBF7 M@2QX"WAD9 8)P%HQ:N7EQ]N.P]H:DY:ZC<(%0HZ8 -;H0Y;?
MI?'X6L]>2U9*(,&=^0"7\Y*)8,15VMB&4UI+*N"N?@]1"]A3K@%D$BBR3(QS
MJ@ $IT+Q2Y#;N;!G4^?6:O37W&":VF:DEF3LS;&<0S;23W/2G:6(^BAE8+9T
MN$HC,@R<AEB&"ZQ@="R13..2E1,P%7]N%G-S*U 5$>O)PIQFOI&B^.YXL$=,
MQH\+!#3#F!0"2",-2DZO8=@R+CL =Z:KF-]EUE36A/7) <B,'&)$FN&!@5MA
MDRH@16FJ/9U9PYW#*D+QC-FW-FI#6VP%XV@*-F]IJK>[\P_8K<!O<<BBD(*[
M%-PVHMQO<X"I0.TK*?(X<,6QIC"&\XI[[A'M2".&]TI[=Z8K4%[RU[,9 85B
MUZ,)K>CWZVO)?$UU&J'M@01$&<^=0DSKAF#8V+ *:TBSU=Q0LYM%+,.N183T
MS^*FNJ;]NDS.D)P7V7$&88N&RSP3IZ1DK!T9B$FLQ9PF2^[MLD/W>]-FL #M
M\PO;>6Q4A.%O=RZ9A;EA^9MQ'JB>)MY$6S?D)%962?< >HP$]T?Y=4:0#VL,
MHT!,J',J&9BAVK@RU-2KJ +M^7AW^UEP0#W=@J,"U@'; U;=?U#GQ</]X-G3
MG=V=,-C'JG5\\//@/ZA(_3U6CZ>P<-Q7KT$I[%DIW_Q?%)ME#@3; LJ'BK/2
MZ2A^7U.4V[;%:3V9(I7RCE^CXT"'BUI1J.S85O )K$"HAGMYP1V9PKSPI?<4
M:XKNWU2[IV;8CVT;2^;.9A=I56GI]=0_UND,.,SS#V6@@PZU[1J1TG:0;*%@
M[2RU4$C\%)X60$+<]OH4(RTJ<& 8J=^-1-JYFE)5# '8'K%^[\*\OIJD=+8
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M0.AT.P0($D&H'>43I#F-&']FC<<=9FPK!L#]C,7P"J4GRBU4@YK01JLS)"#
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M;]PO]Q96>^1_4$L! A0#%     @ <(ME63C,BG4-(@  $[@  !<
M     ( !     &5A,#(R,#$Q.2TX:U]P97)A<V\N:'1M4$L! A0#%     @
M<(ME6;?NMN4-.0  9CX! !P              ( !0B(  &5A,#(R,#$Q.3 Q
M97@Q,"TQ7W!E<F%S;RYH=&U02P$"% ,4    " !PBV59RDR&&R11  "\LP$
M&P              @ &)6P  96$P,C(P,3$Y,#%E>#0M,5]P97)A<V\N:'1M
M4$L! A0#%     @ <(ME6=1.-"W*50  '<L! !L              ( !YJP
M &5A,#(R,#$Q.3 Q97@T+3)?<&5R87-O+FAT;5!+ 0(4 Q0    ( '"+95F\
M12SGC%   ."B 0 ;              "  >D" 0!E83 R,C Q,3DP,65X-"TS
M7W!E<F%S;RYH=&U02P$"% ,4    " !PBV59?S%%>$D,  #@+0  '
M        @ &N4P$ 96$P,C(P,3$Y,#%E>#DY+3%?<&5R87-O+FAT;5!+ 0(4
M Q0    ( '"+95F=:.>S*P,  .8+   1              "  3%@ 0!P<G-O
M+3(P,C0Q,3 U+GAS9%!+ 0(4 Q0    ( '"+95D5 [XZ_@H  ("&   5
M          "  8MC 0!P<G-O+3(P,C0Q,3 U7VQA8BYX;6Q02P$"% ,4
M" !PBV59?!D@@E<'  #75P  %0              @ &\;@$ <')S;RTR,#(T
B,3$P-5]P<F4N>&UL4$L%!@     )  D >0(  $9V 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea0220119-8k_peraso_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prso-20241105.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000890394</identifier>
        </entity>
        <period>
            <startDate>2024-11-05</startDate>
            <endDate>2024-11-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-05" id="Fact000004">0000890394</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-05" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-05" id="Fact000010">2024-11-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-05" id="Fact000011">PERASO INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2024-11-05" id="Fact000012">000-32929</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-05" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-05" id="Fact000014">77-0291941</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-05" id="Fact000015">2309 Bering Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-05" id="Fact000016">San Jose</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-05" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-05" id="Fact000018">95131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-05" id="Fact000019">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-05" id="Fact000020">418-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-05" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-05" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-05" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-05" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-11-05" id="Fact000025">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-11-05" id="Fact000026">PRSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-11-05" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-05" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
